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ABSTRACT 
INTERACTIONS BETWEEN MALARIA (PLASMODIUM YOELII) 
AND LEISHMANIASIS (LEISHMANIA MEXICANA AMAZONENSIS), 
WITH A NOTE ON THE BLOOD-FEEDING BEHAVIOR OF 
LUTZOMYIA LONGIPALPIS. 
(February, 1988) 
Russell E. Coleman 
B.S., SUNY at Binghamton 
M.S., University of Tennessee/Knoxville 
Ph.D., University of Massachusetts/Amherst 
Directed by: Professor John D. Edman 
Evidence has suggested that delicate immunological balances 
that normally prevent establishment of Leishmania infections are up¬ 
set following stress (i.e., malaria), resulting in the development of 
clinical leishmaniasis. This study was undertaken to determine 1) 
whether concomitant infection with Plasmodium yoelii would result in 
more severe Leishmania mexicana infection 2) whether immunomodulating 
agents would affect the development of these parasites, 3) whether 
chemotherapy directed at L. mexicana would affect the progression of 
P. yoelii, and 4) whether host anti-vector defensive behavior would 
be affected during concomitant infections. 
Laboratory mice were infected with L. mexicana and P. yoelii. 
These mice developed more severe infections than did animals infected 
with either parasite alone. Maximum disease enhancement resulted 
when the interval between the inoculation of the two parasites was 
minimized. Several C/57 mice infected with both pathogens developed 
v i I 
disseminated L. mexicana infections. Dissemination was never 
observed in control mice. 
Leishmania mexicana infected mice were treated with immuno- 
modulating agents. Cimetidine, ranitidine, and 2'-deoxyguanosine 
were as effective as pentostam, an antileishmanial agent, at limiting 
parasite development. Plasmodium yoelii infected mice which were 
treated with pentostam developed more severe malaria than did cim¬ 
etidine treated mice or control animals. Both agents limited L. 
mexicana development in mice infected with both L. mexicana and P. 
yoelii; however, cimetidine reduced P. yoelii infection in these mice 
whereas pentostam increased the severity of the malaria. 
Mosquitoes (Aedes aegypti) were unable to feed on uninfected 
mice or on mice infected with either P. yoelii or L. mexicana. 
Significantly more mosquitoes engorged on mice infected with both 
pathogens. Maximum engorgement occurred during the crisis phase of 
the enhanced malarial infection. Other parameters which were exam¬ 
ined were altered during peak malarial infection in these dually 
infected animals. 
Results of this study indicate that concomitant infection with 
PIasmodium yoe1ii and Leishmania mexicana can influence parasite 
development in laboratory mice. Not only were clinical symptoms 
affected, but vector feeding success was enhanced during dual infec¬ 
tions. These factors may be critical to the epidemiology of the dis¬ 
ease. The efficacy of certain chemotherapeutic agents was also 
markedly affected in these dually infected animals. 
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Chapter 1 
LITERATURE REVIEW 
Malaria 
Malaria is caused by protozoan parasites belonging to the genus 
Plasmodium (Family Plasmodiidae). These organisms undergo two stages 
of asexual reproduction (schizogony) in the vertebrate host and one 
stage of sexual reproduction (sporogony) in the mosquito vector. 
Asexual reproduction initially occurs in the parenchymal cells of the 
liver, followed by a subsequent erythrocytic cycle (Bruce-Chwatt 
1985). 
There are approximately 120 recognized Plasmodium; of these, 
only P. falciparum, P. vivax, P. ovale, and P. malariae infect humans 
(Garnham 1966 1980). The remaining species are parasites of birds, 
reptiles, primates, rodents, bats, and various other small mammals 
(Bruce-Chwatt 1985, Killick-Kendrick & Peters 1978). Sixty species 
of anopheline mosquitoes (Diptera: Culicidae) transmit P. falciparum, 
P. vivax, P. ovale, and P. malariae to humans (Bruce-Chwatt 1970, 
Garnham 1966). 
Clinical symptoms of malaria typically include fever and anemia 
(Aikawa et al. 1974, Maegraith 1977, 1981). Anemia results primarily 
from the destruction of parasitized erythrocytes, although decreased 
1 
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production of red blood cells by the bone marrow contributes to the 
decreased hematocrit (Pasvol & Wilson 1982, Seed & Kreier 1980). 
Fever presumably results from the release of endogenous pyrogen from 
leucocytes in response to the production of toxic products of the 
parasite. The pyrogen interacts with receptors on the hypothalamus, 
resulting in the release of prostaglandin and monoamines. These 
agents signal sympathetic nerve fibers to constrict peripheral blood 
vessels (Bruce-Chwatt 1985, Evered & Whelan 1983). 
Leishmaniasis 
Leishmaniasis is a vector-borne disease that occurs on all con¬ 
tinents except Australia and Antarctica (Zuckerman & Lainson 1977). 
Leishmaniasis is transmitted by various phlebotomine sand flies 
(Diptera: Psychodidae) in the genera Phlebotomus and Lutzomyia (Lewis 
1974, Ward 1977 1985). Estimates on the annual incidence of the dis¬ 
ease range from 400,000 (Chance 1981) to 12 million (Walsh & Warren 
1979) human cases. The disease is primarily a zoonosis, with the ex¬ 
ception of visceral leishmaniasis in India and on the east coast of 
China (Chang et al. 1985). 
Leishmaniasis is caused by parasites belonging to the protozoan 
genus Leishmania Ross 1903 (Family: Trypanosoraatidae) (Chang et al. 
1985). The Leishmania are taxonomically separated into 2 distinct 
groups, the Peripylaria and the Subpylaria, which are differentiated 
according to the position of the parasite within the vector (Lainson 
& Shaw 1979). Six species of Leishmania infect humans: Leishmania 
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mexicana, L. major, L. donovoni, L. braziliensis, L. tropica, and L. 
aethiopica (Molyneux & Ashford 1983). The parasite exists as an ex¬ 
tracellular flagellated form in the digestive tract of phlebotomine 
sand flies and as a non-motile amastigote in the macrophage of the 
vertebrate host (Molyneux & Ashford 1983). Amastigotes are taken up 
by the sand fly during feeding. The amastigotes differentiate into 
promastigotes and begin to divide soon after ingestion. The para¬ 
sites initially colonize the midgut or hindgut of the fly (Killick- 
Kendrick et al. 1974, Rioux et al. 1979). Colonization subsequently 
extends forward until the pharynx is reached. There, promastigotes 
attach to the cuticle (Killick-Kendrick 1979, Killick-Kendrick et al. 
1974, Walters et al. 1987). Promastigotes can eventually be found in 
the proboscis of the fly, from where they find their way into the 
skin of the mammalian host during feeding (Chang et al. 1985). Pro- 
mastigotes are initially non-infective to the vertebrate; however, 
sequential development leads to the production of infective forms 
(Sacks & Perkins 1984, 1985). 
Numerous studies have shown that infected sand flies have dif¬ 
ficulty in obtaining blood (Adler & Ber 1941, Chung et al. 1951, 
Strangways-Dixon & Lainson 1966, Williams 1966). Killick-Kendrick et 
al. (1977) observed that infected sand flies took second and third 
blood meals with great difficulty, and Killick-Kendrick and Molyneux 
(1981) suggested that promastigotes interfered with sensilla control¬ 
ling probing and engorgement. Sensilla in the proboscis have been 
described by Killick-Kendrick and Molyneux (1981), and Lewis (1984) 
described the cibarial sensilla of sand flies. Interference with the 
4 
sensilla could result in parasite detachment from the pharynx and 
lead to their deposition in the skin of the host. Recent studies 
have clearly shown that vector probing ability is altered when para¬ 
sites are present (Beach et al. 1984, 1985, Killick-Kendrick et al. 
1985). Congestion of parasites at the stomodeal valve and in the an¬ 
terior foregut may result in a backwash of blood during feeding, 
resulting in the egestion of parasites (Jefferies et al. 1986, 
Warburg & Schlein 1986). 
Once in the host, invading promastigotes are rapidly taken up 
by macrophages, where transformation to the amastigote form occurs. 
Parasites rapidly divide and the macrophage eventually ruptures, re¬ 
leasing the parasites into the tissue from where they invade fresh 
cells (Molyneux & Ashford 1983). 
Three distinct forms of leishmaniasis occur in humans. These 
are visceral leishmaniasis, cutaneous leishmaniasis, and mucocuta¬ 
neous leishmaniasis (Marsden & Jones 1985). Visceral leishmaniasis 
is caused by L. donovoni donovoni (Naik 1979), L. donovoni infantum 
(Bettini et al. 1981) or L. donovoni chagasi. Following inoculation 
of proraastigotes by the sand fly vector, the parasites are taken up 
by macrophages in the liver, spleen, bone marrow, and lymph nodes. 
The characteristic clinical symptom at this stage of infection is an 
intermittent fever• The disease rapidly progresses unless appropri¬ 
ate therapy is initiated. Symptoms during advanced infection include 
prolonged fever and hepatosplenomegaly. Death normally results from 
bacterial sepsis or hemorrhage (Marsden & Jones 1985). 
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Cutaneous leishmaniasis is caused by several species of Leish- 
mania, including L. mexicana, L. braziliensis, L. tropica, and L. 
major (Lainson & Shaw 1973, Manson-Bahr 1971). As with other forms 
of leishmaniasis, promastigotes are inoculated into the skin by sand 
flies. Amastigotes are taken up by macrophages, undergo division, 
rupture the cell, and are taken up by fresh macrophages. The host 
mounts an immune response in which an initial invasion of polymor¬ 
phonuclear leukocytes is followed by an infiltration of lymphocytes. 
Ulceration results from a combination of cellular infiltration, 
edema, and vasculitis, leading to a poor blood supply and necrosis 
(Marsden & Jones 1985). Blood stream dissemination of parasites oc¬ 
curs rarely. 
Leishmania braziliensis braziliensis is the primary pathogen 
responsible for mucocutaneous leishmaniasis. Parasites metastasize 
from an original skin lesion to the blood vessels around the nasal 
septum. Parasites may then spread to the buccal cavity, pharynx, and 
larynx (Molyneux & Ashford 1983). 
Parasite Interactions 
Despite extensive control efforts, vector-borne diseases remain 
an immense obstacle to social and economic development in the tropics 
(BOSTID 1983). Malaria, filariasis (including onchoceriasis), try¬ 
panosomiasis, and leishmaniasis debilitate hundreds of millions of 
people annually and have resisted most of our control efforts. The 
resurgence of malaria is of particular concern, and malaria is now 
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considered endemic or epidemic throughout much of Africa, southern 
Asia, and South and Central America. The World Health Organization 
(WHO) initiated its campaign to eradicate malaria in 1956, and by 
1970, 727 million people were no longer at risk from malaria (WHO 
1979). As recently as 1978, popular literature had reported that 
malaria had been wiped out (Phillips 1983); however, nothing could be 
further from the truth. In Africa, where the WHO eradication program 
was never implemented, malaria control efforts have had little suc¬ 
cess, and malaria remains an indigenous problem to the general 
population. In other countries, initial success has been replaced 
with a dramatic resurgence of malaria (Bruce-Chwatt 1985). Drug 
resistant Plasmodium, insecticide resistant Anopheles mosquitoes, 
poor anti-mosquito control measures, as well as financial and admin¬ 
istrative shortcomings have all led to this rebound (WHO 1979). Sri 
Lanka, India, Pakistan, Bangladesh, and Turkey are notable for the 
rising incidence of malaria following the almost total elimination of 
the disease in these countries (WHO 1983). 
Resurgence of malaria in these third-world countries has led to 
an increased number of problems which can be directly attributed to 
malaria outbreaks, such as increased medical costs, depletion of 
limited fiscal resources, and loss of labor. Lower infant birth 
rates and higher rates of prenatal mortality have been reported 
(Brabin 1983, Bray & Anderson 1979, Bruce-Chwatt 1983, Gilles et al. 
1969, Jelliffe 1968), while the incidence of lymphoma's has increased 
greatly in malaria endemic areas (Salaman 1970). Indirect effects of 
malaria, such as interaction with concomitant pathogens, have been 
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reported. Historically, suppression of Treponema pallidum, a 
causative organism of neurosyphilis, via malarial febrile paroxyms, 
was a noted medical benefit of pathogen interaction (Bruce-Chwatt 
1985). 
Enhancement, as well as suppression, of concomitant infections 
has also been attributed to Plasmodium infection. Many infectious 
diseases, such as leishmaniasis, trypanosomiasis, and shistosomiasis, 
coincide geographically with malaria. Malaria may influence the 
course of these diseases, changing an otherwise non-lethal infection 
into one with serious sequelae. Children infected with P. falciparum 
are abnormally susceptible to bacterial infections (Greenwood et al. 
1971), and malaria has been shown to exert an effect on murine onco¬ 
genic viruses (Salaman et al. 1969), granuloma formation by Shisto- 
soma mansoni (Abdel-Wahab et al. 1974, Lwin et al. 1982), and on the 
spontaneous invasion of tissue by Giardia muris (Radelescu et al. 
1971). Numerous other studies have corroborated the enhancing role 
Plasmodium infections can have on concurrent microbial infections 
(Bomford & Wedderburn 1973, Thurston 1955, Strickland et al. 1972). 
The immunosuppressive role of malaria appears to be almost en¬ 
tirely responsible for these enhanced infections (Killick-Kendrick & 
Peters 1978). Immunosuppressive effects of malaria have been docu¬ 
mented in a number of laboratory studies (Freeman 1978, Greenwood et 
al. 1971, Khansari et al. 1981, Lelchuk & Playfair 1980); however, 
the mechanism has not been entirely elucidated (Khansari et al. 
1981). Suppression of humoral responses is clear (Barker 1971); the 
role of cell-mediated immunosuppression less so (Zuckerman 1977). 
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The rodent malaria, P. berghei, purportedly exerts its immunosuppres¬ 
sive effect by an action either on bone-marrow derived lymphocytes or 
on macrophages (Greenwood et al. 1971). More recently, suppressor 
cells derived from T and macrophage lineages have been implicated 
(Weinbaum et al. 1978, Correa et al. 1980), as have soluble secreted 
substances (Khansari et al. 1981). Functional impairment of relevant 
immunological cells may also result in immunosuppression (Greenwood 
et al. 1971, Loose et al. 1972, Wedderburn 1974). Additional 
research is needed before the precise mechanism of Plasmodium 
mediated immunosuppression is determined. 
Leishmaniasis coincides geographically with human malaria in 
numerous areas of the world (WHO 1984, Harwood & James 1979). Evi¬ 
dence suggests that species of Leishmania, as well as Plasmodium 
species, exert strong immunosuppressive effects (WHO 1984). Suppres¬ 
sion of cellular immunity mediated by macrophages and sensitized T 
cells appears to be the primary mechanism of Leishmania mediated im¬ 
munosuppression (Howard et al. 1980, Nickol & Bonventre 1985a 1985b 
1985c). Unlike malaria, leishmaniasis is primarily and endemic dis¬ 
ease with normally localized occurrence. In humans, many Leishmania 
infections terminate subclinically (Molyneux & Ashford 1983, WHO 
1984). Studies have indicated that exposure to L. donovoni does not 
necessarily result in clinical symptoms (Fuller et al. 1979, 
Pampiglione et al. 1974). Up to 64% of individuals examined in 
Ethiopia tested positive for the Leishmanin skin test. However, only 
2 of the 2723 individuals tested had active L. donovoni infections 
(Fuller et al. 1979). This suggests a high incidence of cryptic 
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infections (Fuller et al. 1979). Circumstantial evidence suggests 
that delicate immunological balances that normally prevent establish¬ 
ment of Leishmania infections are commonly upset following stress 
(e.g., famine, war, and epidemic malaria) and result in the develop¬ 
ment of clinical leishmaniasis (Corkill 1948). 
The potential for both concurrent and asynchronous Plasmodium - 
Leishmania infections readily exists, based on their respective geo¬ 
graphic ranges and seasonal patterns. Geographic overlap, in con¬ 
junction with the known immunosuppressive effects of each parasite, 
suggests that concurrent Plasmodium and Leishmania infections could 
each suppress immune function. This would theoretically increase the 
severity of the complementary disease. Decreased immunocompetence 
following recovery from acute P. falciparum infection has been demon¬ 
strated (Greenwood et al. 1972, McGregor 1972). Hence, dual infec¬ 
tions need not be simultaneous in order for disease enhancement of 
occur. 
The incidence of leishmaniasis has been shown to decrease 
markedly in areas where intensive malaria control efforts are imple¬ 
mented (Molyneux & Ashford 1983). Elimination of endophilic sand 
flies due to the use of residual pesticides directed at Anopheles 
mosquitoes has been suggested as the primary cause of this decrease. 
However, epidemiological evidence suggests that leishmaniasis is pre¬ 
dominantly a rural disease. High risk groups include military per¬ 
sonnel, woodcutters, hunters, etc., indicating that endophilic sand 
flies are probably not the primary vectors of leishmaniasis in many 
instances. We suggest that it may be the absence of Plasmodium 
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infections (resulting from malarial control efforts), rather than the 
elimination of suitable vectors, that resulted in the corresponding 
decrease in the incidence of clinical cases of leishmaniasis. 
In the only experimental study of dual malaria - leishmaniasis 
infections, the interactions between P. berghei and L. infantum was 
examined in the golden hamster (Adler 1954). Protection against the 
normally lethal P. berghei was found in hamsters previously infected 
with a virulent strain of L. infantum. Infection with P. berghei did 
not inhibit or promote multiplication of L. infantum. The model used 
by Adler is not directly applicable to typical human infections, as 
both L. infantum and P. berghei are more highly virulent in the ham¬ 
ster than any human Plasmodium of Leishmania species. 
Chemothe rapy 
Malaria 
Different species of Plasmodium vary in their susceptibility to 
antimalarial drugs, and not all life stages are affected by a given 
agent (Rieckmann & Silverman 1977). Drugs used for the treatment of 
malaria can be divided into two major groups of compounds, i) prophy¬ 
lactic agents, which prevent the establishment of the parasite in the 
liver, and ii) schizonticides, which attack the parasites in the red 
blood cell (Bruce-Chwatt 1985). Compounds which are effective anti- 
malarial agents include antifolates, 8-aminoquinolines, 4-arainoquino- 
lines, artemisinine, and various antibiotics (WHO 1984b). 
Chinchona alkaloids, and in particular quinine, have been used 
to treat malaria for over 300 years (Bruce-Chwatt 1985). Various new 
agents which have been synthesized in recent years have largely re¬ 
placed quinine; however, as the incidence of drug resistant Plasmod¬ 
ium increases, use of quinine is increasing. Quinine is primarily 
used in treating severe cases of malaria that do not respond to other 
agents. Prolonged administration of quinine can result in signifi¬ 
cant side-effects (Rieckmann & Silverman 1977). 
The 8-aminoquinolines are active against primary tissue stages, 
hypnozoites (those liver forms that result in parasite relapse), ga- 
metocytes, and asexual blood stages (WHO 1984b). Primaquine, the 
most widely used 8-aminoquinoline, is not used alone for the treat¬ 
ment or prevention of malaria. This agent is primarily used i) to 
prevent relapses of malaria, or ii) in conjunction with other agents 
to prevent the spread of drug resistant parasites (Bruce-Chwatt 
1985). 
Chloroquine, a 4-aminoquinoline, is the most widely used anti- 
malarial drug. Its initial success was an important component of the 
WHO global malaria eradication campaign, and the spread of resistance 
to the compound contributed to the demise of the program (Moore & 
Lanier 1961, Harinasuta et al. 1962). Chloroquine is effective both 
as a blood schizontocide and as a prophylactic agent and also de¬ 
stroys gametocytes of P. vivax, P. ovale, and P. malariae» but not P. 
falciparum. Side-effects are uncommon. The schizontocidal toxicity 
of chloroquine results from the selective uptake of the agent by in¬ 
fected erythrocytes (WHO 1984b). Chloroquine resistance may result 
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from the active efflux of chloroquine from infected erythrocytes, ef¬ 
fectively preventing the accumulation of toxic levels of the compound 
in the cell (Martin et al. 1987). Use of verapamil, a calcium chan¬ 
nel blocker, can effectively reverse drug resistance by inhibiting 
the efflux of chloroquine from infected erythrocytes (Martin et al. 
1987). 
Mefloquine is a substituted 4-quinoline methanol that is struc¬ 
turally similar to quinine. It is a highly efficient schizonticidal 
that is effective against chloroquine, pyrimethamine resistant P. 
falciparum and against P. vivax (Bruce-Chwatt 1985). Side effects 
are minimal at therapeutic doses. 
The antifolates include pyrimethamine and proguanil (WHO 
1984b). These agents inhibit dihydrofolate reductase or dihy- 
dropteroate synthetase and are effective against all multiplying 
stages of the parasite. Various antibiotics, including monocycline, 
doxycycline, lincomycin, and clindamycin affect developing liver 
stages and blood stages. These agents are inhibitors of ribosomal 
protein synthesis in prokaryotes, and are normally used following 
treatment with quinine (WHO 1984b). Artemisinine (qinghaosu) is a 
sesquiterpene lactone isolated from the plant Artemisia annua. 
Quinghaosu is active against chloroquine resistant P. falciparum in 
humans, and acts synergistically with mefloquine (WHO 1984b). 
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Leishmaniasis 
All forms of old world cutaneous leishmaniasis heal sponta¬ 
neously, and in the new world, infection with L. mexicana normally 
results in benign lesions. Treatment of these forms of disease may 
not be required unless multiple lesions occur or unless lesions are 
located on a cosmetically important site (Marsden & Jones 1985). Due 
to the danger of metastasis and the development of mucocutaneous 
leishmaniasis, infection with L. braziliensis requires mandatory 
treatment. Likewise, clinical visceral leishmaniasis can be unifor- 
mally fatal unless treatment is initiated (Rees et al. 1985). 
All forms of leishmaniasis are initially treated with pentava- 
lent antimony in the form of sodium stibogluconate (pentostam) or N- 
methyl glucanime antimonate (glucantime) (Berman 1985). The mode of 
action of these agents is unknown. Treatment failure or relapse oc¬ 
curs in approximately 10-25% of the cases where these agents are used 
(Berman 1983). Therapeutic doses of pentavalent antimonials are also 
associated with a variety of toxic side effects. Malaise, anorexia, 
and vomiting appear early in the treatment, with electrocardiograph 
alterations and occasional renal insufficiency (Marsden & Jones 
1985). 
Secondary treatment for leishmaniasis normally consists of pen¬ 
tamidine of amphotericin B. However, these agents are expensive, 
relatively toxic, and treatments are lengthy (Berman 1985). Intense 
efforts are therefore currently underway to develop new therapeutic 
drugs. Agents which show promise include allopurinol (Kager et al. 
1981, Walton et al. 1983), nifurtimox (Marsden et al. 1979), 
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pyrimethamine (Neal 1976), various 8-aminoquinolines (Kinnamon et al. 
1978), and chlorpromazine (Pearson et al. 1982). 
The use of liposome-encapsulated agents has greatly reduced the 
amount of drug required to treat leishmaniasis (Alving & Swartz 1984, 
Reed et al. 1984). Liposomes are vesicles which form spontaneously 
when lipids are dispersed in aqueous media. Any drugs present in the 
media will be partially incorporated into the the aqueous phase 
between the lipid rings. Liposomes are rapidly removed from the 
circulatory system by the reticuloendethelial cells of the liver and 
spleen (Juliano 1982, Scherphof 1982). Therapeutic agents incorpo¬ 
rated within the liposomes are then available to kill any parasites 
within the macrophage, but are themselves effectively sequestered 
from the rest of the body (Black et al. 1977, New et al. 1978, Reed 
et al. 1984). 
Immuno-modulation 
The use of therapeutic agents which modulate immune responses 
could be of great value in the prophylaxis and treatment of infec¬ 
tious diseases (Drews 1985). Three classes of compounds which affect 
immune function have received widespread attention. These include 
substances which affect purine metabolism in lymphocytes, histamine 
H2 blockers, and various products of immune cells (Drews 1985). 
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Host-Vector Interactions 
Vector-borne diseases, such as leishmaniasis and malaria, de¬ 
pend upon the frequency and success of host/vector interactions for 
transmission. Vector contact with an infected host, successful up¬ 
take of infected fluid, and, after a given period of time, subsequent 
contact and feeding upon a susceptible host, are implicit in the pro¬ 
cess of transmission. These components of arthropod-borne diseases 
have received increasing attention (Balashov 1984, Day & Edman 1983, 
1984a, 1984b, Day et al. 1983, Edman et al. 1972, 1974). The numeri¬ 
cal abundance of the vector population, their longevity under condi¬ 
tions favorable to parasite development, and the affinity of the 
arthropod for vertebrates capable of harboring the parasite are among 
the more important characteristics relevant to the transmission pro¬ 
cess (Reeves 1971). 
Host behavior can clearly play an important role in determining 
whether a parasite has an opportunity to be transmitted by an arthro¬ 
pod (Day & Edman 1984b, Edman et al. 1974, Waage & Nondo 1982, Walker 
& Edman 1985 1986). In some instances modification of host behavior 
may be induced by a parasite, resulting in an increased probability 
of pathogen transmission (Dawkins 1982). Rodent defensive behavior 
normally prevents mosquitoes from successfully feeding upon them, 
thereby eliminating the possibility of disease transmission. How¬ 
ever, lab mice infected with Plasmodium berghei. P. chabaudi, or P. 
^■°elli exhibited periods of reduced defensive behavior which corre¬ 
sponded to maximum gametocyte infectivity. This period did not 
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necessarily correspond with maximum parasitemia (Day & Edman 1983a). 
Dye and Hasibeder (1986) examined the dynamics of vector-borne dis¬ 
eases when non-random host/vector contact occurred. 
Arthropod behavior may also be manipulated by the parasite in 
such a way that transmission of the pathogen is facilitated. Two op¬ 
posing processes which affect feeding success, vector contact and 
impairment of feeding processes, are known to promote disease trans¬ 
mission. 
Vector contact with the host is fraught with risks, primarily 
due to host defensive behavior. Rapid feeding minimizes the period 
spent by the vector on the host without sacrificing maximum nutrient 
uptake; this presumably increases vector survival (Daniel & King- 
solver 1983, Me11ink 1981). Arthropods minimize host contact by 
releasing antihemostatic salivary components that inhibit platelet 
aggregation and enhance blood location (Ribiero et al. 1984). Numer¬ 
ous vector-borne parasites inhibit host hemostasis. This inhibition 
contributes to blood-finding success (Rossignol et al. 1985). Exam¬ 
ples of alteration of host hemostasis include thrombocytopenia re¬ 
sulting from malaria, dengue, African trypanosomiasis, leishmaniasis, 
and babesiosis (Allen et al. 1975, Davis 1982, Halstead 1984), hemor¬ 
rhagic disorders caused by Rift Valley fever virus, and vasodilation 
resulting from infection with Rocky Mountain spotted fever and en¬ 
demic typhus (Rossignol et al. 1985). 
Alternatively, impairment of processes affecting feeding may 
also facilitate pathogen transmission. Numerous studies have shown 
that parasites can cause pathology to the vector. Arthropods 
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infected with Leishmania (Beach et al. 1985), Plasmodium (Rossignol 
et al. 1984 1986), and trypanosomes (Anez & East 1984, Jenni et al. 
1980) probe more frequently than their uninfected counterparts. 
Mosquitoes infected with La Crosse virus have an impaired ability to 
feed, and therefore may contact more hosts during a single 
gonotrophic period (Grimstad et al. 1980). A combination of impaired 
probing ability with host defensive behaviors may extend feeding time 
and/or increase the number of hosts contacted by an infected insect. 
Chapter II 
INTERACTIONS BETWEEN PLASMODIUM YOELII AND 
LEISHMANIA MEXICANA AMAZONENSIS IN LEISHMANIA 
SUSCEPTIBLE BALB/C MICE 
Introduction 
Human leishmaniasis is a protozoan disease with a wide spectrum 
of clinical manifestations (Turk & Bryceson 1971, Belehu et al. 
1980). Three primary forms of human disease have been described. 
Each of these forms may exhibit a variety of symptoms (Molyneux & 
Ashford 1983), ranging from inapparent infections (Pampiglione et al. 
1974) to fulminating cases with fatal sequelae (Hill 1986). The 
clinical symptoms that develop in a given individual reflect proper¬ 
ties of the parasite involved as well as intrinsic host features, 
such as genetic background and immunological competence (Blackwell & 
Ulczak 1984, Hill 1986, Semprevivo et al. 1981). 
Evidence suggests that clinically apparent cases of leishmania¬ 
sis, no matter how severe the symptoms are once these cases become 
established, comprise only a small fraction of all actual infections 
(Pampiglione et al. 1974, Fuller et al. 1976 1979). Serological evi¬ 
dence has shown that cryptic L. donovoni infections are widespread in 
Ethiopia (Ayele & Ali 1984, Fuller et al. 1976, 1979) and Italy 
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(Pampiglione et al. 1974), yet clinically evident cases of visceral 
leishmaniasis are quite rare in these countries. American cutaneous 
leishmaniasis may occur as a cryptic infection (Gustafson et al. 
1985), and L. braziliensis has been shown to remain latent for many 
years without the development of clinical symptoms (Walton et al. 
1973). 
The factors which determine whether or not an individual will 
develop clinically evident leishmaniasis have not been conclusively 
determined. Laboratory studies have shown that the genetic back¬ 
ground of the host is important. Different strains of inbred mice 
vary greatly in their response to Leishmania. Some strains are com¬ 
pletely resistant to the parasite while others are acutely suscepti- 
ble (Howard et al. 1980, Perez et al. 1979, Semprevivo et al. 1981). 
The immunological competence of the host also affects disease outcome 
(Liew et al. 1982). The development of leishmaniasis at the site of 
inoculation and in metastatic visceral and cutaneous foci is influ¬ 
enced by host immunity. Failure of immune function has been sug¬ 
gested as a primary factor that may lead to the development of 
disseminated forms of leishmaniasis (Hill 1986). 
Any factor that has the capacity to alter immunological func¬ 
tion could theoretically affect the course of leishmaniasis. Pam¬ 
piglione et al. (1974) suggested that stress, i.e. famine or epidemic 
malaria, could affect the competence of the immune system. This 
could transform an inapparent infection into a clinically evident 
case of leishmaniasis. Walton et al. (1973) proposed that tubercu¬ 
losis could upset immunological function, thereby precipitating the 
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invasion of mucosal tissue by L. braziliensis after many years of 
asymptomatic infection. 
Outbreaks of visceral leishmaniasis are common following 
epidemics of malaria (Pampiglione et al. 1974). Malaria coincides 
geographically with leishmaniasis in many parts of the tropics. 
Numerous studies have shown that infection with malaria can result in 
the enhancement of concomitant infections, presumably via an immuno¬ 
suppressive mechanism (Greenwood 1974, Khansari et al. 1981, Killick- 
Kendrick & Peters 1978, Krettli 1977, Lelchuk & Playfair 1980, Lwin 
et al. 1982). Malaria-mediated immunosuppression has been implicated 
in the development of Burkitt's lymphoma (Salaman 1970), and loss of 
cellular-mediated immunity due to malaria can lead to reactivation of 
herpes simplex viruses (Cook 1985). 
In the only study on concomitant leishmaniasis and malaria, 
Adler (1954) examined interactions between P. berghei and L. infantum 
in the golden hamster, Mesocricetus auratus. Animals previously 
infected with L. infantum were somewhat resistant to the normally 
lethal P. berghei. There was no evidence that either infection was 
enhanced in dually infected animals. 
The purpose of this study was to determine whether concurrent 
infection with malaria would result in enhanced leishmaniasis in 
highly susceptible mice. Interactions between Plasmodium yoelii and 
Leishmania mexicana were examined in BALB/c mice. These mice are a 
satisfactory model for progressive cutaneous leishmaniasis (Perez 
1983). The interval between the inoculation of each parasite was 
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varied. This allowed me to examine the role of the timing of inocu¬ 
lation of each parasite on the course of the concomitant pathogen. 
Materials and Methods 
Animals 
Female BALB/c mice were obtained from the Charles River Breed¬ 
ing Laboratory, Wilmington, Massachusetts. Eight-week-old female 
mice weighing 25-30 g were used for all experiments. 
Malaria 
The 17x strain of Plasmodium yoelii was used. It was kindly 
provided by Dr. J. Day. It is maintained in our laboratory by weekly 
passage of infected blood in BALB/c mice. Inocula were prepared from 
red blood cells (RBC) collected in phosphate-buffered saline (PBS) 
from the tail of an infected mouse. The percent of infected RBC were 
determined from Giemsa-stained thin blood smears. A hemocytometer 
was used to determine the actual number of RBC per unit volume. 
Blood was then diluted with PBS so that each mouse received 1 x 10^ 
infected RBC i.p. in 0.2 ml. The course of infection was monitored 
by determining P. yoelii parasitemia in Giemsa-stained blood smears 
(the percent of RBC infected with P. yoelii is presented as the 
"index of malaria" in all Figures). Blood smears were prepared every 
2 days until no parasites were found over a 6 day period. All mice 
were monitored once a week thereafter to check for possible relapses 
of the Plasmodium 
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Leishmaniasis 
The Walter Reed strain 227 of Leishmania mexicana amazonensis 
was used. The source and history of this isolate have been described 
(Nolan et al. 1984). Amastigotes were obtained from donor mice 7-10 
weeks after subcutaneous inoculation of 2 x 106 amastigotes into the 
right-rear footpad. The doner was sacrificed and the infected foot 
amputated, surface sterilized with 70% ETOH, and homogenized in a 
Ten-Broeck glass tissue grinder containing 3-4 ml PBS. Debris was 
allowed to settle, then the supernatant pipetted off for use. 
Amastigote viability was determined using the method of Hodgkinson 
and Herman (1980) and the number of parasites per unit volume calcu¬ 
lated using a Petroff-Housser bacterial cell counting chamber. The 
solution was adjusted with PBS to obtain a final concentration of 
either 1 x 10^ or 2 x 10^ viable amastigotes in 10 microliters PBS. 
Mice were infected by subcutaneously inoculating 10 microliters of 
the appropriate solution into the ventral surface of the right-rear- 
footpad. The thickness of the infected footpad was measured once a 
week using a direct-reading vernier caliper. Measurements commenced 
1 week prior to the inoculation of L. mexicana and continued for at 
least 10 weeks. Lesion diameter was expressed as the thickness of 
the infected footpad in millimeters minus the thickness of the 
contralateral uninfected footpad (the mean adjusted lesion diameter 
is expressed as the "Index of Leishmaniasis" in all Figures). 
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Experimental Design 
An initial experiment was designed to test our experimental 
protocol for precision and reliability. Three groups of 30 mice each 
were infected with either 1 x 10^ L. mexicana amastigotes, 2 x 10^ L. 
mexicana amastigotes, or 1 x 106 P. yoelii infected RBC. Mean values 
were recorded and plotted. 
Five additional experiments were conducted. The interval be¬ 
tween the inoculation of the two parasites was varied in each 
experiment, as follows: 
1) P. yoelii followed by L. mexicana in 2 days 
(1 x 10^ amastigotes). 
2) P. yoelii followed by L. mexicana in 3 weeks 
(2 x 10^ amastigotes). 
3) P. yoelii followed by L. mexicana in 20 weeks 
(2 x 10^ amastigotes). 
L* mexicana (2 x 10^ amastigotes) followed by 
P. yoelii in 3 weeks. 
h' mexicana (2 x 10^ amastigotes) followed by 
F. yoelii in 12 weeks. 
Four groups of 10 mice each were used for each of the 5 experi¬ 
ments. These groups consisted of: 1) uninfected mice, 2) P. yoelii 
infected mice, 3) L. mexicana infected mice, and 4) P. yoelii and L. 
mexicana infected mice. Mean P. yoelii parasitemia rate and mean L. 
-XiCana lesion size *ere recorded for each group of mice in each ex¬ 
periment . 
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Results 
Consistent P. yoelii and L. mexicana infections were produced 
in the initial experiment (Figs. 1 & 2). Based on these results I 
believed that similar precision and consistency would be expected 
during experiments on dual infections. 
Results from the 5 experiments examining interactions between 
parasites are shown in Figs. 3-7. Peak malaria infections with 10- 
15% infected RBC's occurred in mice inoculated with P. yoelii only. 
None of these mice died. When P. yoe 1 ii was preceded by L. mexicana, 
the malaria infection was both enhanced and prolonged (Figs 3, 4, & 
6). Up to 50% of the mice in these groups died. 
Two different doses of L. mexicana were used to inoculate mice. 
Regardless of the dose, L. mexicana infections were more severe in 
those mice where P. yoelii was inoculated at or around the same time 
as L. mexicana compared to mice infected with L. mexicana only (Figs. 
3, 4, & 5). This enhancement of the leishmaniasis began within 1-2 
weeks following the elimination of P. yoelii from the peripheral 
blood and continued for the duration of the infection. When P. 
Xoelii was inoculated 20 weeks prior to L. mexicana no enhancement of 
the leishmaniasis occurred (Fig. 7). 
Figure 1. Course of Plasmodium yoelii in 30 BALB/c mice. 
Mice were infected on Day 0 (+/- SE). 
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Figure 2. Course of Leishmania mexicana in BALB/c 
mice infected with 1 x 106 or 2 x 10° amastigotes. Mice 
were infected on Week 0 (+/- SE). 
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Figure 3. Interactions between Plasmodium yoelii and 
Leishmania mexicana in BALB/c mice. L. mexicana followed 
by P. yoelii in two days (+/- SE). 
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Figure 4. Interactions between Plasmodium yoelii and 
Leishmania mexicana in BALB/c mice. L. mexicana followed 
by P. yoelii in three weeks (+/- SE). 
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Figure 5. Interactions between Plasmodium yoelii and 
Leishmania mexicana in BALB/c mice. P. yoelii followed by 
L. mexicana in three weeks (+/- SE). 
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Figure 6. Interactions between Plasmodium yoelii and 
Leishmania mexicana in BALB/c mice. L. mexicana followed 
by P. yoelii in twelve weeks (+/- SE). 
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Figure 7. Interactions between Plasmodium yoelii and 
Leishmania mexicana in BALB/c mice. P. yoelii followed by 
L. mexicana in twenty weeks (+/- SE). 
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Discussion 
The primary objective of this research was to determine if con¬ 
comitant infection with malaria would result in more acute leishmani¬ 
asis in the susceptible BALB/c mouse. Results clearly demonstrated 
(see Fig. 3) that not only did malaria enhance the course of cuta¬ 
neous leishmaniasis, but that fatality rates of up to 50% could be 
ascribed to the malaria in those mice infected with both L. mexicana 
and the normally non-lethal P. yoelii. These findings suggest that 
in those regions of the world where malaria coincides geographically 
with leishmaniasis, clinical incidence and severity of the diseases 
in humans also could be influenced by concomitant infections. 
Under natural conditions the two infections often may not ini¬ 
tiate at the same time. With this in mind, experiments were designed 
to determine the effect if the malaria or leishmaniasis were initi¬ 
ated well before or after the other infection. Results presented in 
Figs. 4 and 5 clearly demonstrate that the leishmanial infection is 
enhanced if the malaria is introduced 3 weeks before or after the 
Leishmania inoculation. Similarly, the malaria was enhanced in all 
cases of concomitant infection (see Figs. 3, 4, & 6). Somewhat sur¬ 
prisingly, enhancement of P. yoelii parasitemia was minimal when that 
parasite was inoculated during advanced L. mexicana infection (Fig. 
5). Existing knowledge indicates that cell-mediated immunity is sup¬ 
pressed during this stage of the infection (Howard et al. 1981). Why 
the malarial infection was not affected more significantly is not 
known. The most pronounced influenc e of leishmaniasis upon the 
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malaria occurred when the former was inoculated only a few days 
before the latter (see Fig. 3). However, even when the malarial 
infection was initiated 3 weeks before the leishmaniasis it had a 
strong influence on the leishmanial infection. In both these situa¬ 
tions the concomitant infection strongly influenced the capacity of 
the host to resist the second infection, yet the original infections 
were either subpatent or apparently eliminated. Documentation of the 
effect of concomitant infections in humans may require not only imme¬ 
diate examination for dual infections but significant follow-up and 
knowledge of the patient's history. 
Although the mechanism by which each of these parasitic infec¬ 
tions enhances the other is not known, it has been established that 
each elicits immune suppressor activity. In many areas of the world 
where multiple parasitic infections in humans may be the rule rather 
than the exception, specific and nonspecific immune suppression re¬ 
sulting from previous, concurrent, or subpatent infections may be of 
considerable influence to chemotherapeutic and immunologic interven¬ 
tion . 
These results are in direct contrast to those obtained by Adler 
(1954), who found that infection with L. infantum in the golden ham¬ 
ster protected against the normally lethal P. berghei. Existing 
knowledge on the role of cell-mediated immunity during malaria and 
leishmaniasis indicates that suppression of immune function should 
lead to enhancement, not suppression, of concomitant infections. 
Disease enhancement may be a general phenomenon resulting from con- 
comitant malarial - leishmanial infections. 
Chapter III 
INTERACTIONS BETWEEN PLASMODIUM YOELII AND 
LEISHMANIA MEXICANA AMAZONENSIS IN LEISHMANIA 
RESISTANT C/57 MICE 
Introduction 
Human disease due to infection with Leishmania mexicana nor¬ 
mally consists of a single lesion which spontaneously heals (Perez et 
al. 1978). Recovery is usually accompanied by the development of 
delayed hypersensitivity response to leishmanin as well as immunity 
to reinfection by the parasite. 
Various strains of inbred mice are commonly used as experimen¬ 
tal hosts for L. mexicana (Barrel et al. 1983, Neal & Hale 1983, 
Perez et al. 1978, 1979). Different strains of mice vary greatly in 
their responses to L. mexicana. Some mice (e.g., C/57 strain) are 
resistant to L. mexicana while others (e.g., BALB/c strain) are 
acutely susceptible to the parasite (Perez et al. 1979). 
Numerous studies have shown that infection with malaria can 
result in the enhancement of concomitant infections, presumably via 
an immunosuppressive mechanism (Greenwood 1974, Khansari et al. 1981, 
Killick-Kendrick & Peters 1978, Krettli 1977, Lelchuk & Playfair 
1980, Lwin et al. 1982). The purpose of this study was to determine 
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whether concurrent infection with malaria would result in enhanced 
leishmaniasis in a Leishmania-resistant mouse strain. 
Interactions between Plasmodium yoelii and L. mexicana amazon- 
ensis were examined in C/57 mice. The interval between the inocula¬ 
tion of each parasite was varied. Similar experiments were previ¬ 
ously conducted in Leishmania—susceptible BALB/c mice; however, the 
presentation of L. mexicana in BALB/c mice does not reflect the 
normal course of the parasite in humans. In this respect C/57 mice 
provide a more realistic model for studying interactions between 
malaria and leishmaniasis. 
Materials and Methods 
Animals 
Female C/57 mice were obtained from the Charles River Breeding 
Laboratory, Wilmington, Massachusetts. Eight-week-old mice weighing 
25-30 g were used for all experiments. 
Malaria 
Techniques for inoculating and quantifying P. yoelii have been 
described (Chapter 2). 
Leishmaniasis 
Techniques for inoculating and quantifying L. mexicana amazon- 
~ns^- have been described (Chapter 2). 
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Experimental Design 
An initial experiment was designed to test the experimental 
protocol for the inoculation and quantification of L. mexicana in 
C/57 mice. Two groups of 30 mice each were infected with either 1 x 
10^ or 2 x 10^ L. mexicana amastigotes. Mean lesion diameters were 
recorded. 
Five additional experiments were conducted. The interval 
between the inoculation of P. yoelii and L. mexicana was varied in 
each experiment, as follows: 
1) P. yoelii followed by L. mexicana (1 x 10^ 
amastigotes) in 2 day. 
2) P. yoelii followed by L. mexicana (2 x 10^ 
amastigotes) in 3 weeks. 
3) P. yoelii followed by L. mexicana (2 x 106 
amastigotes) in 16 weeks. 
4) L. mexicana (2 x 106 amastigotes) followed by 
P. yoelii in 3 weeks. 
5) L« mexicana (2 x 10^ amastigotes) followed by 
P. yoelii in 12 weeks. 
Four groups of 10 mice each were used for each of the 5 experi¬ 
ments. These groups consisted of: 1) uninfected mice, 2) P. yoelii 
infected mice, 3) L. mexicana infected mice, and 4) P. yoelii and L. 
mexicana infected mice. Mean P. yoelii parasitemia rate and mean L. 
mexicana lesion size were recorded for each group of mice in each ex¬ 
periment . 
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Results 
Consistent Leishmania infections were produced with both 
dosages of L. mexicana in the initial experiment (Fig. 8). Results 
from experiments examining interactions between parasites are shown 
in Figures 9-13. The P. yoelii infection was significantly enhanced 
in those instances where L. mexicana was inoculated prior to the 
malaria (Figs. 9, 10, & 12). L. mexicana lesions were greater in 
mice where the malaria was inoculated before or slightly after the 
leishmaniasis (Figs. 9, 10, 11, & 13). 
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mice 
were 
Figure 8. Course 
infected with 1 x 
infected on Week 0 
of Leishmania mexicana 
106 or 2 x 106 
(+/- SE). 
_ in C/57 
amastigotes. Mice 
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Figure 9. Interactions between Plasmodium yoelii and 
Leishmania mexicana in C/57 mice. L. mexicana followed by 
P. yoelii in two days ( + /- SE). 
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Figure 10. Interactions between Plasmodium yoelii and 
Leishmania mexicana in C/57 mice. L. mexicana followed by 
P. yoelii in three weeks (+/- SE). 
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Figure 11. Interactions between Plasmodium yoelii and 
Leishmania mexicana in C/57 mice. P. yoelii followed by L. 
mexicana in three weeks (+/- SE). 
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Figure 12. Interactions between Plasmodium yoelii and 
Leishmania mexicana in C/57 mice. L. mexicana followed by 
P. yoelii in twelve weeks (+/- SE). 
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Figure 13. Interactions between Plasmodium yoelii and 
Leishmania mexicana in C/57 mice. P. yoelii followed by L. 
mexicana in twelve weeks (+/- SE). 
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Discussion 
Previous experiments examined interactions between P. yoelii 
and L. mexicana in BALB/c mice. BALB/c mice infected with L. mexi- 
cana developed fulminating lesions which did not heal. Infection 
with P. yoelii resulted in these mice becoming even more susceptible 
to L. mexicana. Under certain circumstances the presence of L. mexi¬ 
cana also resulted in more severe malaria compared to mice infected 
only with P. yoelii. 
In humans, L. mexicana normally produces a single lesion which 
heals spontaneously (Perez et al. 1978). Infection produced by L. 
mexicana in BALB/c mice therefore does not provide a comparable model 
of human disease. C/57 mice infected with L. mexicana develop 
lesions which initially ulcerate but subsequently heal. These benign 
lesions resemble those normally produced in humans by L. mexicana 
(Perez et al. 1979). 
Results from the present study support previous conclusions 
based on interactions between P. yoelii and L. mexicana in BALB/c 
mice. Plasmodium yoelii parasitemia was markedly enhanced whenever 
L. mexicana was inoculated prior to the malaria (Figs. 9, 10, & 12). 
In BALB/c mice, significant mortality occurred during dual infec¬ 
tions, whereas no deaths occurred in C/57 mice. Maximum disease 
enhancement occurred when the interval between inoculation of P. 
yoelii and L. mexicana was short (Figs. 9 & 10). As in BALB/c mice, 
increased P. yoelii parasitemia occurred prior to the development of 
clinically evident leishmaniasis (Fig. 9). 
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Surprisingly, inoculation of L. mexicana followed by P. yoelii 
in 12 weeks produced little enhancement of either the malaria or the 
leishmaniasis (Fig. 12). These results support those in BALB/c mice. 
While we have not examined immunological function during dual infec¬ 
tions, lesion size decreased after week 8. This suggests that the 
host immune system was actively responding to L. mexicana by 12 weeks 
post-inoculation. Any effect produced by P. yoelii at this point 
might not influence the progression of L. mexicana in the mouse. It 
is also possible that establishment of L. mexicana within the host is 
affected by P. yoelii. Once established, the course of leishmaniasis 
might progress independently of concomitant parasites. 
In regions of the world where malaria and leishmaniasis coin¬ 
cide geographically, interactions between these parasites may play an 
important role in determining disease outcome. Our results clearly 
demonstrate that not only is the clinical infection important in 
determining the course of concomitant parasitic infections, but that 
prior patent, or subpatent infections have the ability to affect 
disease outcome as well. Recognition and treatment of subpatent 
infections therefore might be of considerable significance to the 
success of primary treatment. 
Chapter IV 
METASTASIS OF LEISHMANIA MEXICANA AMAZONENSIS IN 
LEISHMANIA RESISTANT C/57 MICE FOLLOWING 
CONCOMITANT INFECTION WITH PLASMODIUM YOELII 
Introduction 
American cutaneous leishmaniasis (ACL) results from infection 
with Leishmania mexicana or L. braziliensis (Perez 1983). ACL ex¬ 
hibits a wide spectrum of clinical symptoms. In most instances the 
infection consists of a spontaneously healing ulcerative lesion 
(Barral et al. 1983). However, non-ulcerative lesions which eventu¬ 
ally disseminate may occur (Perez et al. 1978). It is believed that 
the clinical manifestations of ACL reflect properties of the parasite 
involved as well as genetic background and immunological competence 
of the host (Hill 1986, Pearson et al. 1983). 
Several murine models have been developed which mimic the di¬ 
verse symptoms of ACL. Inbred C/57 mice normally develop localized 
lesions which spontaneously heal, similar to the most common forms of 
ACL in humans. On the other end of the spectrum, BALB/c mice exhibit 
symptoms that are characteristic of disseminated ACL (Perez et al. 
1979). These strain differences purportedly reflect differences in 
the genetic susceptibility of the host. We report here on the 
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development of disseminated leishmaniasis in a Leishmania resistant 
strain of mouse (C/57) following a non—lethal malaria infection. 
Materials and Methods 
Animals 
C/57 mice were obtained from the Charles River Breeding Labora¬ 
tory, Wilmington, Massachusetts. 
Malaria 
Procedures for inoculating and quantifying P. yoelii have been 
described (Chapter 2). 
Leishmaniasis 
The Walter Reed strain 227 of Leishmania mexicana amazonensis 
was used to infect mice. Procedures for inoculating this parasite 
have been previously described (Chapter 2). After inoculation of L. 
mexicana, the diameter of the infected footpad and the contra-lateral 
uninfected footpad (control) were measured weekly with a direct read¬ 
ing vernier caliper. 
Experimental design 
Twenty mice were inoculated with L. mexicana only. Ten addi¬ 
tional mice were inoculated intra-peritoneally with L. mexicana 
followed by 1 x 106 Plasmodium yoelii infected RBC in 3 weeks. 
Development of L. mexicana was quantified for each group of mice. 
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Results 
Lesion development in mice infected only with L. mexicana is 
shown in Figure 14. Lesion diameter peaked at about 8 weeks post¬ 
inoculation, with gradual healing of the foot thereafter. No dissem¬ 
ination to the contra-lateral footpad occurred. This observation has 
been confirmed in numerous other experiments. We have followed the 
course of infection of L. mexicana in approximately 150 C/57 mice for 
periods ranging from 1-1 1/2 years. In none of these mice did any 
visible dissemination of the parasites occur. 
Footpad lesion size was greatly enhanced in those mice infected 
with both L. mexicana and P. yoelii. Mean maximum lesion size in 
these mice peaked at 14-16 mm in diameter, compared to a 10 mm diame¬ 
ter in mice infected only with L. mexicana. Three of the mice in¬ 
fected with both P. yoelii and L. mexicana developed lesions which 
reached a maximum diameter of 27 mm at 20 weeks post-inoculation. 
Atrophy of the foot thereafter resulted in a decrease in measurable 
lesion diameter, but did not indicate healing had occurred. All 3 of 
these mice developed lesions in the contra-lateral uninfected footpad 
at around 18 weeks post-inoculation (Figure 14). Metastatic lesions 
were also evident in the nasal and tail regions of 1 of these mice. 
62 
Figure 14. Footpad Diameter in mice infected with only 
Leishmania mexicana (N = 20), and in 3 mice infected with both 
Leishmania mexicana and Plasmodium yoelii that developed 
disseminated lesions. L. mexicana was inoculated at week 0 and 
P. yoelii at week 3. 
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Discussion 
Why some individuals develop disseminated ACL is not known. 
Barrel et al. (1983) found that a given parasite strain could cause 
both diffuse cutaneous leishmaniasis and muco-cutaneous leishmania¬ 
sis. They suggested that the clinical expression of the parasite was 
determined by the host response. Dissemination of the pathogen oc¬ 
curred only after mice were over a year old. Progressive depression 
of cell-mediated immunity, as pointed out by Gardner (1980), was 
suggested as possibly contributing to disease manifestation at this 
point. Dissemination of L. mexicana in this study occurred when mice 
were only 26 - 35 weeks old, suggesting that deterioration of the 
immune system did not play a role in parasite dissemination. Failure 
of immune mechanisms has also been suggested as a factor that could 
lead to development of disseminated ACL (Hill 1986). Walton et al. 
(1973) believed that pulmonary tuberculosis, alone or combined with 
severe malnutrition, could possibly breach immune defenses. This 
would precipitate invasion of mucosal tissue by L. braziliensis after 
years of latent infection. 
Malaria is a well documented suppressor of immune function 
(Lelchuk & Playfair I960, Lwin et al. 1982), and numerous studies 
have shown that malaria can enhance the course of concomitant infec¬ 
tions (Cook 1985, Krettli 1977, Salaman et al. 1969). Our results 
suggest that concurrent infection with malaria has the potential to 
change a normally trivial Leishmania infection into one with serious 
consequences. 
Chapter V 
EFFECT OF CIMETIDINE, RANITIDINE, AND 2'-DEOXYGUANOSINE 
ON THE DEVELOPMENT OF LEISHMANIA MEXICANA AMAZONENSIS 
IN LEISHMANIA SUSCEPTIBLE BALB/C MICE AND IN 
LEISHMANIA RESISTANT C/57 MICE 
Introduction 
Leishmaniasis is a disease infecting millions of people in 
tropical and semitropical regions (Marinkelle 1980). Infection in 
vertebrate hosts is initiated through inoculation of flagellated 
promastigote forms by the sand fly vector. Promastigotes are taken 
up by mononucleated phagocytic cells and differentiate into amas- 
tigotes, which function as obligate intracellular parasites (Molyneux 
& Ashford 1983). 
Pentavalent antiraonials are the drugs most often used to treat 
leishmaniasis. Other compounds may be used when parasites respond 
poorly to these agents (Rees et al. 1985). Currently available 
chemotherapeutic agents have a number of drawbacks, including signif¬ 
icant numbers of treatment failures (Bryceson et al. 1985, Thakur et 
al. 1984), occasional unexplained deaths (Rees et al. 1985), and po¬ 
tentially debilitating side effects (Peters et al. 1980, Thakur 
1986). New> safer and cheaper antilelshmanial agents are urgently 
needed (Marsden et al. 1979, Peters et al. 1980). 
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Host defense against Leishmania is believed to be modulated by 
cell-mediated immunity (Murray et al. 1986). Recovery from infection 
has been shown to be mediated by T cells in inbred strains of mice. 
Production of macrophage-activating lymphokines by spleen cells is 
important to the development of resistance (Coutinho et al. 1984, 
Scott & Sher 1986). Leishmania susceptible (e.g., BALB/c) mice char¬ 
acteristically exhibit a suppression of cell-mediated immune re¬ 
sponses (Liew et al. 1982, Murray et al. 1986). In these non-cure 
mice, suppressor T cells may initiate anergy (Blackwell & Ulczak 
1984, Nickol & Bonventre 1985a 1985b). 
Modulation of immune response offers a potential means of con¬ 
trolling leishmaniasis. Monoclonal antibodies against specific T 
cell subsets have been used therapeutically to treat susceptible mice 
infected with leishmaniasis (Titus et al. 1985), and specific trans¬ 
fer of T cell populations has been shown to enhance delayed hypersen¬ 
sitivity responses to L. major (Lima et al. 1984). A number of 
agents are currently used to control various human diseases by modu¬ 
lating immune response (Bender et al. 1984, Bril et al. 1984, Drews 
1985, Osband et al. 1981). Cimetidine is an H-2 histamine receptor 
antagonist which can inhibit T suppressor cell function (Zapata Sir- 
vent et al. 1985). It also can enhance proliferative responses of 
peripheral blood lymphocytes (Gifford et al. I960). Cimetidine has 
been used successfully to control peptic ulcers (Brogden et al. 1978) 
and tumors (Osband et al. 1981), and can restore suppressed immunity 
following burns (Bender et al. 1984). Ranitidine is also a H2 his¬ 
tamine receptor antagonist, but the central imidazole group found in 
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cimetidine has been replaced with a furan ring, and a side chain has 
been slightly modified (Henry et al. 1980). The result is a compound 
which inhibits the binding of histamine to H2 receptors yet has 
little affinity for other sites (Zeldis et al. 1983). T suppressor 
cell activity is also affected by 2'-deoxyguanosine. This agent acts 
by inhibiting the enzyme ribonucleotide reductase, thereby preventing 
DNA synthesis in these cells (Bril et al. 1984). 
The purpose of this study was to determine if cimetidine, rani¬ 
tidine, and 2'-deoxyguanosine could be used to control L. mexicana 
amazonensis infection in BALB/c mice. Sodium stibogluconate 
(pentostam) is a widely used antileishmanial drug. This agent was 
therefore used as a baseline drug against which to compare the effi¬ 
cacy of these immuno-modulating agents. 
Materials and Methods 
Animals 
BALB/c and C/57 mice were obtained from the Charles River 
Breeding Laboratory, Wilmington, Massachusetts. Eight-week-old 
females weighing 25-30 g were used for all experiments. 
Leishmaniasis 
Walter Reed strain 227 of Leishmania mexicana amazonensis was 
used. The source and history of this isolate have been described 
(Nolan et al. 1984), as have methods for the purification and inocu¬ 
lation of parasites (Chapter 2). Amastigotes were obtained from 
donor mice. The donor 
was sacrificed and the infected foot 
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amputated, surface sterilized with 70% ETOH, and homogenized in a 
Ten-Broeck glass tissue grinder. Amastigote viability was determined 
by the method of Hodgkinson and Herman (1980) and the number of para¬ 
sites per unit volume calculated by using a Petroff-Housser bacterial 
cell counting chamber. The solution was adjusted with PBS to obtain 
a final concentration of 102, 103, 104, 105, or 106 viable amastig- 
otes in 10 ul PBS. Mice were infected by subcutaneously inoculating 
10 ul of the appropriate solution into the ventral surface of the 
right rear-footpad. The thickness of the infected footpad was 
measured weekly with a direct-reading vernier caliper. Measurements 
commenced 1 week prior to the inoculation of L. mexicana and contin¬ 
ued for 10 (BALB/c) or 20 (C/57) weeks. Lesion diameter was ex¬ 
pressed as the thickness of the infected footpad in millimeters minus 
the thickness of the contralateral uninfected footpad. 
Drug treatment 
Drug treatment commenced 1 day after inoculation of L. mexicana 
into mice, and was continued once daily for either 10 or 20 days. 
Thereafter, mice were inoculated once a week until the conclusion of 
the experiment. Inocula were delivered in 0.5 ml PBS. Control mice 
received only PBS. Experimental groups consisted of 10 (BALB/c mice) 
or 20 (C/57 mice) animals. 
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Experimental groups 
Experiment i. The BALB/c mice in this experiment received 
either cimetidine (20 mg/kg/day) or pentostam (200 mg/kg/day) once 
daily for 10 days. 
Experiment ii. The BALB/c mice in this experiment received 
either cimetidine (40 mg/kg/day), pentostam (200 mg/kg/day), or 2'- 
deoxyguanosine (40 mg/kg/day) once daily over a 20 day period. 
Experiment iii. BALB/c mice in this experiment were inoculated 
with combinations of cimetidine (40 mg/kg/day) and pentostam (200 
mg/kg/day), cimetidine (40 mg/kg/day) and 2'—deoxyguanosine (40 
mg/kg/day), or pentostam (200 mg/kg/day) and 2'—deoxyguanosine (40 
mg/kg/day). The drugs were given once daily over a 20 day period. 
Experiment iv. Eight groups of BALB/c mice were infected with 
10 -* Mexicana amastigotes in this experiment. Mice in each group 
were treated with cimetidine or ranitidine in one of the following 
doses: 40, 80, 160, or 320 mg/kg/mouse/day. A control group 
received PBS. 
Experiment v. Ten groups of BALB/c mice were used in this 
experiment. Two groups of mice were each infected with 102, 103, 
10 ’ 10 ’ or lt)6 viable L. mexicana amastigotes. One group of mice 
infected with each inocula received either cimetidine or ranitidine 
at a dose of 80 mg/kg/mouse/day. Control mice for each treatment 
received only PBS. 
Experiment vi. In this experiment, two groups of C57 mice were 
infected with 106 L. mexicana amastigotes and treated with either 
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cimetidine or ranitidine (80 mg/kg/mouse/day). A control group 
received PBS. 
Results 
Experiment i 
Results from the first experiment are shown in Fig. 15. 
Lesions in mice which had received cimetidine or pentostam were 
consistently smaller than the lesions in control mice. The amount of 
variation in lesion size within each group of mice was initally 
small. However, the degree of variation increased markedly between 6 
and 9 weeks post-inoculation in those mice treated with cimetidine. 
Experiment ii 
Increasing the dose of cimetidine or 2'-deoxyguanosine and/or 
the duration of treatment resulted in the development of smaller 
lesions than in control animals. Cimetidine produced the most marked 
therapeutic effect, whereas pentostam and 2'-deoxyguanosine resulted 
in less impressive control (Fig. 16). 
Experiment iii 
All combinations of drugs were more effective at controlling 
lesion development than were therapeutic regimes in which either pen¬ 
tostam or 2'-deoxyguanosine was used alone (Fig. 17). However, none 
of the drug combinations which were tested were more effective at 
controlling L. mexicana infections than cimetidine (Figs. 16 and 17). 
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Experiment iv 
Results from the fourth experiment are shown in Figs. 18 and 
19. Increasing the doses of both cimetidine (Fig. 18) and ranitidine 
(Fig. 19) from 40 mg/kg/mouse/day to 320 mg/kg/mouse/day resulted in 
a corresponding decrease in the diameter of lesions. No mortality 
was observed, except in that group of mice receiving ranitidine at a 
dose of 320 mg/kg/day. Seven of the eight mice in this group died 
within 2 h of the first drug treatment. Significant lesion reduction 
was observed as early as 4 weeks post-inoculation with both agents 
(Figs. 18 & 19). Complete resolution resulting from drug treatment 
was not noted in any instance. 
Experiment v 
When the infective inocula of L. mexicana was increased a cor¬ 
responding increase in lesion diameter was observed (Figs. 20-24). 
Neither cimetidine (80 mg/kg/day) nor ranitidine (80 mg/kg/day) had a 
marked effect on lesion development in those mice infected with only 
lo2 or 103 amastigotes (Figs. 20 & 21). Cimetidine was more effec¬ 
tive than ranitidine when the infective dose consisted of 104 
amastigotes (Fig. 22), while ranitidine was more efficient at limit¬ 
ing lesion development when mice were infected with 105 or 106 
amastigotes (Figs. 23 & 24). No mortality occurred in any of these 
mice. 
Experiment vi 
The progression of L. mexicana amazonensis in BALB/c mice is 
markedly different that that 
normally seen in humans infected with 
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this pathogen. In this respect C/57 mice provide a more realistic 
model of human infection with the parasite. Both cimetidine and 
rantidine were effective at limiting the development of L. mexicana 
in these mice (Fig. 25). Lesions in both experimental groups were 
smaller throughout the course of the infection, and healing of 
lesions occurred more rapidly in treated mice than in control mice 
(Fig. 25). 
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Figure 15. Effect of cimetidine (20 mg/kg/day) and 
pentostam (200 mg/kg/day) on the development of Leishmania 
mexicana in BALB/c mice. Drugs were given for a 10 day period 
commencing 1 day after inoculation of L. mexicana ( + /- SE). 
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Figure 16. Effect of ciraetidine (40 rag/kg/day), pentostam 
(200 mg/kg/day), and 2'-deoxyguanosine (40 mg/kg/day) on the 
development of Leishmania mexicana in BALB/c mice. Drugs were 
given for a 20 day period commencing 1 day after inoculation of 
L. mexicana (+/- SE). 
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Figure 17. Effect of cimetidine (40 mg/kg/day) and 
pentostam (200 mg/kg/day), 2'-deoxyguanosine (40 mg/kg/day) and 
pentostam (200 mg/kg/day), and cimetidine (40mg/kg/day) and 
2'-deoxyguanosine (40 mg/kg/day), on the development of 
Leishmania mexicana in BALB/c mice. Drugs were given for a 20 
day period commencing 1 day after inoculation of L. mexicana 
(+/- SE). 
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Figure 18. Effect of cimetidine (40, 80, 160, and 320 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 10^ 
amastigotes at Week 0 (+/- SE). 
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Figure 19. Effect of ranitidine (40, 80, 160, and 320 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 10^ 
amastigotes at Week 0 (+/- SE). 
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Figure 20. Effect of cimetidine and ranitidine (80 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 102 
viable amastigotes on Week 0 (+/- SE). 
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Figure 21. Effect of cimetidine and ranitidine (80 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 10^ 
viable amastigotes on Week 0 (+/- SE). 
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Figure 22. Effect of cimetidine and ranitidine (80 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 104 
viable amastigotes on Week 0 (+/- SE). 
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Figure 23. Effect of cimetidine and ranitidine (80 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 10 
viable amastigotes on Week 0 (+/- SE). 
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Figure 24. Effect of cimetidine and ranitidine (80 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in BALB/c mice. Mice were infected with 10^ 
viable amastigotes on Week 0 (+/- SE). 
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Figure 25. Effect of cimetidine and ranitidine (80 
mg/kg/day) on the development of Leishmania mexicana 
amazonensis in C/57 mice. Mice were infected with 10^ 
viable amastigotes on Week 0 (+/- SE). 
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Discussion 
Mice infected with cutaneous leishmaniasis can be divided into 
"healers" and "non-healers." Specific immune responses control the 
infection in "healers", whereas in susceptible mice suppressor T 
cells abrogate potentially curative cell-mediated immunity (Howard et 
al. 1980). These results suggest that specific immunotherapy aimed 
at T suppressor cells can provide control superior to that obtained 
with pentostam in BALB/c mice. 
Cimetidine, an agent that inhibits T suppressor cell function, 
can evidently affect the development of L. mexicana amazonensis in 
BALB/c and C/57 mice. This control persisted through the course of 
the infection. In most instances where the immuno—restorative effect 
of cimetidine has been examined, the development of a particular 
disease was slowed rather than completely resolved (Osband et al. 
1981, Gifford et al. 1981). In no instance, in Leishmania suscepti¬ 
ble or resistant mice, did cimetidine completely eliminate the devel¬ 
opment of clinical symptoms of cutaneous leishmaniasis, supporting 
these previous data. 
Cimetidine affects the function of all cells bearing the H-2 
histamine receptor (Zapata-Sirvent et al. 1985). Ranitidine also 
competitively inhibits the binding of histamine to H2-receptors; how¬ 
ever, unlike cimetidine, ranitidine purportedly does not bind to 
other sites such as androgen receptors, the hepatic mixed-function 
oxidase system, or peripheral lymphocytes (Zeldis et al. 1983). As 
such, ranitidine should not effect immune function. Although we have 
96 
not examined the immunological response of ranitidine treated mice 
during L. mexicana infections, ranitidine was as effective as cimeti- 
dine at limiting the development of clinical symptoms, suggesting 
that immunological cells might be affected by this agent. 
2'-deoxyguanosine was less effective than cimetidine at con¬ 
trolling lesion development, but more effective than pentostam. 2'- 
deoxyguanosine inhibits replication of T suppressor cells, but does 
not affect the activity of functional cells (Bril et al. 1984), while 
cimetidine affects the function of all cells bearing the H-2 his¬ 
tamine receptor (Zapata-Sirvent et al. 1985). Reduction of T sup¬ 
pressor cell populations is presumably more complete with cimetidine 
than with 2'-deoxyguanosine, possibly explaining the limited effect 
of 2'-deoxyguanosine on development of lesions. 
The BALB/c mouse provides a suitable model to study diffuse 
cutaneous leishmaniasis (DCL); however, the rapid development and 
progression of lesions followed by fatal visceralization is atypical 
of the majority of human infections (Perez et al. 1979). None of the 
agents we used to treat BALB/c mice were completely effective in lim¬ 
iting development of the parasite (Figs. 15-17). In spite of this, 
BALB/c mice proved ideal as an experimental host in which to compare 
the efficacy of various agents at reducing the severity of Leishmania 
derived lesions. Differences in rates of lesion development result¬ 
ing from various drug regimes were easily quantified and significant 
differences were routinely demonstrated. Use of a mouse strain which 
is somewhat more resistant to L. mexicana could provide additional 
evidence on the beneficial effects of immuno-modulating agents. 
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The effect of the infective dose towards parasite development 
is often overlooked, as is the role the infective dose has on the 
efficacy of therapeutic agents. Ranitidine and cimetidine were 
examined under a variety of situations in this study. Both cimeti¬ 
dine and ranitidine were most effective when extraordinary inocula 
were used to infect mice. When lower, presumably more realistic, 
doses of infective inocula were used (i.e., 102 or 103 parasites), 
the effect on lesion development was less dramatic. 
Our results in both BALB/c and C/57 mice suggest that cimeti¬ 
dine and ranitidine have potential as antileishmanial agents. Unless 
an adequate immune response is mounted, muco-cutaneous and diffuse 
cutaneous leishmaniasis often respond poorly to currently used thera¬ 
peutic regimes. Combining agents which affect immune function, such 
as cimetidine, with currently used anti-leishmanial agents might 
diminish the number of therapeutic failures experienced. The wealth 
of literature available on the chemistry, mode of action, and side 
effects of cimetidine increase the attractiveness of this agent 
(Brogden et al. 1978). Although ranitidine is not as widely used as 
cimetidine, a number of studies have indicated that the agent is a 
more potent H2-receptor antagonist than cimetidine. The attractive¬ 
ness of the agent is further augmented by the evident lack of compli¬ 
cating side-effects which may mitigate the efficacy of cimetidine. 
In light of these results, it is somewhat paradoxical that ranitidine 
purportedly does not affect immune function (Zeldis et al. 1983). 
Ranitidine clearly exhibited a curative effect on the development of 
leishmaniasis in mice; in most instances the drug was more effective 
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than cimetidine as an anti-leishmanial agent. However, our results 
do not indicate whether immune function was enhanced or whether the 
agent acted in some other fashion. In view of the limited number of 
agents which are currently used to treat human leishmaniasis, the 
anti-leishmanial potential of cimetidine, ranitidine, and 2'-deoxy- 
guanosine should be examined in further detail. 
Chapter VI 
THE EFFECT OF ANTI-LEISHMANIAL CHEMOTHERAPY ON THE 
DEVELOPMENT OF LEISHMANIASIS (LEISHMANIA MEXICANA AMAZONENSIS) 
AND CONCOMITANT MALARIA (PLASMODIUM YOELII) 
IN LEISHMANIA SUSCEPTIBLE BALB/C MICE 
Introduction 
Many of the currently used chemotherapeutic agents inhibit 
immune function, both in vivo and in vitro (Thong & Ferrante 1978, 
Thong et al. 1978 1979, Hanson 1981). Many protozoan diseases, 
including malaria and leishmaniasis, have well documented immunosup¬ 
pressive capabilities (Bruce-Chwatt 1985, Killick-Kendrick & Peters 
1978, Molyneux & Ashford 1983). The therapeutic use of agents which 
compromise the immune system would only serve to exacerbate the 
problem caused by parasite with known immunosuppressive function 
(Ferrante & Goh 1984). Accordingly, drugs used in the treatment of 
specific diseases could be selected on the basis of their secondary 
effects on immune function, not just on their antiparasitic activity 
(Hanson 1981). 
We have previously shown that concurrent infection with 
Igishmania mexicana amazonensis can influence the development of 
Plasmodium yoelii in BALB/c and C/57 mice (Chapters 2, 3, and 4). 
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Although we have no direct evidence of this, disease enhancement 
which resulted from concomitant infection with these pathogens may be 
due to the well documented immunosuppressive capabilities of these 
parasitic protozoa (Killick-Kendrick & Peters 1978, Liew et al. 1982, 
Murray et al. 1986). We have also demonstrated that agents which 
modulate immune function can effectively be used to treat L. mexicana 
infections in BALB/c and C/57 mice. 2'-deoxyguanosine, cimetidine, 
and ranitidine were as effective at limiting the development of lo¬ 
calized cutaneous lesions in these mice as pentostam, a widely used 
anti-leishmanial agent (Chapters 5 & 6). 
This study was designed to assess the impact of pentostam and 
cimetidine on the development of P. yoelii in BALB/c mice. Plasmod- 
ium y°elii infections were initiated in uninfected mice and in mice 
which had been previously infected with L. mexicana. 
Materials and Methods 
Animals 
Female BALB/c mice were obtained from the Charles River Breed¬ 
ing Laboratory, Wilmington, Massachusetts. Mice were eight weeks old 
and weighed 25-30 g when experiments were initiated. 
Leishmaniasis 
« 
Walter Reed strain 227 of Leishmania mexicana amazonensis was 
used. The source and history of this isolate have been described 
(Nolan et al. 1984), as have methods for the purification and inocu¬ 
lation of parasites (Chapter 2). Mice were infected with 1 x 106 
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amastigotes obtained from donor mice which had been infected 8 weeks 
prior to the initiation of this experiment. Progress of the infec¬ 
tion was determined on a weekly basis by measuring the diameter of 
both rear feet with a direct-reading vernier caliper. The size of 
the lesion (in mm) was calculated by subtracting the measurement 
obtained for the uninfected foot from that of the contralateral 
infected foot. Measurements commenced 1 week prior to the inocula¬ 
tion of L. mexicana and continued for 10 weeks. 
Malaria 
Procedures for the inoculation of experimental animals and the 
quantification of P1asmodium yoe1ii parasitemia have been described 
(Chapter 2). All mice were infected with 1 x 106 infected erythro¬ 
cytes . 
Drug treatment 
Pentostam (200 mg/kg/day) and cimetidine (80 mg/kg/day) were 
used. Drug treatment commenced 1 day after the inoculation of para¬ 
sites and was continued once daily for 20 days. Mice were thereafter 
inoculated once a week until the conclusion of the experiment. Inoc- 
ula were delivered i.p. in 0.5 ml phosphate-buffered saline (PBS), 
with control mice only receiving PBS. 
Experimental groups 
Two experiments were conducted. Mice were treated with pento¬ 
stam in the first experiment and cimetidine in the second. Four 
groups of 20 mice were used in each experiment. These groups 
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consisted of: 1) uninfected mice, 2) P. yoelii infected mice, 3) L. 
mexicana infected mice, and 4) mice infected with both P. yoelii and 
L. mexicana (L. mexicana inoculated 1 day prior to P. yoelii). Ten 
of the mice in each group were treated with the appropriate 
therapeutic agent. The 10 remaining mice were treated with PBS and 
served as controls. 
Results 
The effect of pentostam on parasite development is shown in 
Figures 26—28. Pentostam limited the development of cutaneous 
lesions in mice which were only infected with L. mexicana and in mice 
which were concurrently infected with P. yoelii (Fig. 26). As previ¬ 
ously demonstrated, treatment with pentostam did not "cure” any of 
the mice which were infected with L. mexicana; however, the progres¬ 
sion of the disease was slowed in these animals. 
Plasmodium yoelii infected mice that were treated with pento¬ 
stam developed malaria which was somewhat more severe than that in 
untreated animals (Fig. 27). The infection in these treated mice 
peaked 10 days after pathogen inoculation, when 20% of all erythro¬ 
cytes were parasitized. Parasites were cleared from the peripheral 
circulation by day 16 of the infection. 
Mice which were concomitantly infected with both P. yoelii and 
L. Sgxicana developed more severe malaria than did those mice which 
were only infected with P. yoelii (Figs. 27 & 28). Up to 30 % of all 
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RBC were infected ten days after parasite inoculation, and the infec¬ 
tion was not cleared until 18 days post-inoculation. 
Dually infected mice which were treated with pentostam devel¬ 
oped less severe P. yoelii infections than did dually infected 
animals which were untreated. However, the malaria in these treated 
mice was more severe than that which developed in mice which were 
only infected with P. yoelii (Figs. 27 & 28). 
In Figure 28 the cumulative percent parasitemia in each group 
of mice is plotted over time. Differences in the course of parasite 
development that are not clear when plotted in a normal fashion are 
evident using this format. All animals which were treated with pento¬ 
stam developed more severe malaria than untreated P. yoelii infected 
mice. 
Cimetidine limited the development of leishmaniasis in mice 
infected with L. mexicana and in mice infected with both L. mexicana 
and P. yoelii (Fig. 29). The level of control observed with this 
agent was comparable with that obtained using pentostam. 
Plasmodium yoelii infected mice which were treated with cimeti- 
dine developed less severe malaria than untreated mice. Parasites 
were cleared from the peripheral circulation by 14 days post inocula¬ 
tion in these treated mice compared to 16 days in control animals 
(Figs. 30 & 31). Mice which were concurrently infected with both L. 
—Xlcana and developed significantly more severe malarial 
infections than mice which were only infected with P. yoelii (Figs. 
30 & 31). When these dually infected mice were treated with cimeti¬ 
dine the severity of the Plasmodium infection decreased 
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significantly, both in terms of maximum observed parasitemia as well 
as in the overall duration of the infection (Fig. 30). By plotting 
the cumulative percent parasitemia over time it is possible to 
clearly visualize the effect cimetidine had on parasite development 
(Fig. 31). 
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Figure 26. Effect of pentostara on the development of 
Leishmania mexicana in i) mice infected with L. mexicana 
only, and ii) in mice infected with both P. yoelii and L. 
mexicana. Parasites were inoculated at Week 0 (+/- SE). 
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Figure 27. Effect of pentostara on the development of 
Plasmodium yoelii in mice infected with i) P. yoelii only, 
and ii) in mice infected with both P. yoelii and Leishmania 
mexicana. Parasites were inoculated at Day 0 (+/- SE). 
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Figure 28. Effect of pentostam on the development of 
Plasmodium yoelii in mice infected with P. yoelii only and in 
mice infected with both P. yoelii and Leishmania mexicana: 
Cumulative percent parasitemia as a means of differentiating 
the effects of the drug on malaria. Parasites were inoculated 
at Day 0. 
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Figure 29. Effect of ciraetidine on the development of 
Leishmania mexicana in i) mice only infected with L. mexicana, 
and ii) in mice infected with both Plasmodium yoelTi and L. 
mexicana. Parasites were inoculated at Week 0 (+/- SE). ~~ 
1 12 
T
im
e 
(w
ee
ks
) 
1 13 
Figure 30. Effect of ciraetidine on the development of 
Plasmodium yoelii in mice infected with i) P. yoelii only, 
ii) in mice infected with both P. yoelii and Leishmania 
mexicana. Parasites were inoculated at Day 0 (+/- SE). 
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Figure 31. Effect of cimetidine on the development of 
Plasmodium yoelii in mice infected with P. yoelii only and in 
mice infected with both P. yoelii and Leishmania mexicana: 
Cumulative percent parasitemia as a means of differentiating 
effects of the drug on malaria. Parasites were inoculated at 
Day 0. 
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DISCUSSION 
All forms of human leishmaniasis are initially treated with 
either sodium stibogluconate (pentostam) or N-methyl glucanime 
antimonate (glucantime) (Berman 1985). However, treatment failure or 
relapse occurs in approximately 10-25% of all cases where these 
agents are used (Berman 1983). Therapeutic doses of these pentava- 
lent antimonials are occasionally associated with the development of 
toxic side effects. In cases where these pentavalent antimonials are 
ineffective, secondary treatment consists of either pentamidine or 
amphotericin B. Although these agents are usually effective, their 
utility is offset by their relatively high toxicity, the extended 
treatment regimen, and the unacceptably high cost of these agents 
(Berman 1985). Because none of the currently used chemotherapeutic 
agents are completely satisfactory, intense efforts have been made to 
develop more effective anti-leishmanial agents. Hanson (1981) 
suggested that the choice of a drug for the treatment of a specific 
disease should be based not only on its antiparasitic activity but 
also on its effect on immune function. 
Although we did not directly examine immune function, the 
results of this study indicate that the secondary activity of a given 
agent can affect the course of concomitant parasitic infections. 
Pentostam has no known immuno-modulatory activity, but is quite 
effective in the treatment of human leishmaniasis. However, the use 
of pentostam was associated with an increase in the severity of P. 
Z°elii infections in BALB/c mice. On the other hand, cimetidine 
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modulates T suppressor cell function by inactivating the H2 histamine 
receptors on these cells. Prior to this study, the antiparasitic 
effects of this agent had not been documented. We have previously 
shown that cimetidine is as effective as pentostam at limiting the 
progression of L. mexicana in BALB/c mice. Here we show that cimeti¬ 
dine is also somewhat effective at limiting P. yoelii infection in 
mice; moreover, the ability of this agent to reduce the severe malar¬ 
ial infections that develop in mice concurrently infected with L. 
mexicana was remarkable. 
Numerous parasitic diseases are endemic in human populations 
throughout the tropics. Although reliable figures are not available, 
infection with more than one pathogen is presumably a frequent occur¬ 
rence (Killick-Kendrick & Peters 1978). Parasitic diseases are 
usually treated with specific chemotherapeutic agents. Most of the 
currently used drugs exhibit functional activity against a specific 
parasite or against a group of closely related parasite (Rollo 1980). 
The effectiveness of a given agent is based on its ability to either 
prevent the establishment of a specific pathogen in a susceptible 
host or to eliminate a specific pathogen from an infected individual. 
Little consideration is placed on the ability of a drug to influence 
the course of incidental disease agents which might concomitantly or 
subsequently infect the host. 
Agents with known parasitic activity are occasionally tested 
against unrelated organisms in an attempt to find new drugs for the 
treatment of certain diseases. Miconazole, clotrimazole, and keto- 
conazole were originally developed as antifungal agents; however, 
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these agents also exhibit in vitro antileishmanial activity (Berman 
1981). The 8-aminoquinolines are frequently used in the treatment of 
malaria. Kinnamon et al. (1978) showed that an 8-aminoquinoline (WR 
6026) was highly effective against visceral leishmaniasis. Chloro- 
quine is widely used in the treatment of human malarial infections 
(Bygbjerg & Flachs 1986, Herzog et al. 1983, Rollo 1980). In addi¬ 
tion to its antimalarial capabilities, chloroquine has well known 
anti-inflammatory properties (Rollo 1980) and can inhibit lymphocyte 
proliferation (Bygbjerg & Flachs 1986, Gery & Eidinger 1977, Hurvitz 
& Hirschhorn 1965, Panusch 1975, Salmeron & Lipsky 1983, Trist & 
Weatherall 1981). Treatment with chloroquine has been associated 
with poor antibody response to human rabies vaccine (Taylor et al. 
1984), and chloroquine has a demonstrable viral inhibitory effect 
(Marsh et al. 1983). Chloroquine, mefloquine, and pyrimethamine are 
known to inhibit human natural killer cell cytotoxicity (Ferrante & 
Goh 1984). Somewhat surprisingly, similar studies with other 
chemotherapeutic agents have rarely been conducted. 
It is evident from this study that the choice of a chemothera¬ 
peutic agent can have important effects on both the primary pathogen 
and on secondary parasites. Given the presumed incidence of multiple 
infections in human populations in the tropics, greater emphasis 
should be placed on determination of the parasite burden present in 
each patient. More appropriate therapeutic measures can then be 
undertaken. 
Chapter VII 
INTERACTIONS BETWEEN MALARIA (PLASMODIUM YOELII) AND 
LEISHMANIASIS (LEISHMANIA MEXICANA AMAZONENSIS): 
AFFECT OF CONCOMITANT INFECTION ON PARAMETERS 
AFFECTING DISEASE TRANSMISSION. 
Introduction 
Arthropod transmitted diseases depend on vector blood-feeding 
behavior for transmission. Initial contact with an infected host, 
completion of an extrinsic pathogen incubation period, and subsequent 
feeding on a susceptible vertebrate are implicit to this process. 
Factors which modulate any aspect of blood-feeding behavior can af- 
feet pathogen transmission. 
Mosquito engorgement patterns are often assumed to reflect in¬ 
nate cycles of "hunger" and preference for particular hosts (Washino 
& Terapelis 1967, Tempelis et al. 1970). However, evidence suggests 
that feeding patterns may also be modulated by differences in host 
defensive behavior (Edman & Kale 1971). Many birds and rodents uti¬ 
lize various defensive regimes to prevent mosquitoes from success¬ 
fully engorging (Day & Edman 1984b, Edman & Kale 1971, Edman et al. 
1974, Walker & Edman 1985 1986). In spite of this, a number of 
mosquito-borne diseases are enzootic in these hosts, suggesting that 
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some, as yet unknown, factor(s) allow mosquitoes to feed on these 
animals. 
Laboratory mice use various defensive movements to prevent 
heraatophagous insects from obtaining blood. Day and Edman (1983 
1984b) and Day et al. (1984) found that mice infected with Plasmodium 
berghei, P. chabaudi, or P. yoelii were less effective at preventing 
mosquitoes from obtaining blood than their uninfected counterparts. 
Blood uptake occurred most frequently when gametocytes were preve— 
lant. Modification of host behavior by these parasites presumably 
facilitates pathogen transmission. 
We have previously shown that mice infected with both Leish- 
-ania E£xlcana and P. yoelii develop more severe infections than mice 
infected with either parasite alone (Chapters 2 and 3). The purpose 
of this study was to determine if concurrent infection with these 
pathogens would affect host behavior. Core body temperature, daily 
activity patterns and mosquito engorgement success were the parame¬ 
ters used to assay for behavioral modification. Although Aedes 
aeg^Eti is not a natural vector of either P. yoelii or L. mexicana, 
it served as a bioassay with which to quantify behavioral changes in 
mice infected with these pathogens. 
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Materials and Methods 
Animals 
Female BALB/c mice were obtained from the Charles River Breed¬ 
ing Laboratory, Wilmington, Massachusetts. Mice weighed 25-30 grams 
and were 14 weeks old at the start of experiments. 
Malaria 
The 17x strain of Plasmodium yoelii was used. Procedures for 
the maintanence and inoculation of P. yoelii have been described 
(Chapter 2). Mice were infected with 1 x 106 parasites. 
Leishmaniasis 
Leishmania mexicana amazonensis (Walter Reed strain 227) was 
used. The source and history of this isolate have been described 
“ ■1' I’“>- " «« „d ,„c_ 
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Experimental design 
g ups of 15 mice each were used. One group was sham in- 
jected with 0.5 ml PBS and served as a control. A second group was 
inoculated with P. yoelii. . third with L. mexicana, and the fourth 
with both P. yoelii and L. mexicana. 
Determination of parasitemia 
course of the malaria infection was monitored by determin¬ 
ing P. yoelii parasitemia in Giemsa-stained blood 
smears (Chapter 2). 
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Blood smears were prepared every two days until no parasites were 
found over a six day period- Daily percent parasitemia was plotted 
for each group of mice infected with P. yoelii. 
Leishmania mexicana infections were monitored weekly by record¬ 
ing the thickness of the infected foot and the contralateral unin¬ 
fected foot using a direct-reading vernier caliper. Measurements 
commenced 1 week prior to the inoculation of L. mexicana and contin¬ 
ued throughout the course of the experiment. The size of the lesion 
was calculated by subtracting the measurement (in mm) obtained from 
the uninfected footpad from that of the infected footpad. Mean val¬ 
ues were recorded for each group of mice. 
Mosquitoes 
Aedes aegypti aegypti (L.) (Rockefeller Strain) were maintained 
in the laboratory at 27°C, 70-80X RH, and a 16L:8D regime. Cohorts 
of 1,500 to 2,000 day-old mosquitoes were maintained in screened 
cages. Seven-day old mosquitoes from a given cohort were cold anes¬ 
thetized and sorted by sex. Groups of 10 female mosquitoes were 
placed in screen-topped, one-pint ice-cream cartons. These cartons 
served as holding cages prior to the commencement of experiments. 
AH mosquitoes were provided with 3X sucrose. Experiments were con¬ 
ducted using 8 to 10 day old A. aegypti. 
Mosquito feeding experiments 
Aedes aegypti from the pint holding cartons were aspirated into 
one gallon ice-cream containers with screened lids using a mechanical 
aspirator. Only water was provided while mosquitoes were in these 
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containers. Experiments commenced 24 hr after the introduction of 
mosquitoes into the gallon containers. All experiments were con¬ 
ducted late in the afternoon under fluorescent lights. 
Experiments lasted 45 rain and were initiated with the introduc¬ 
tion of a single mouse into the cage. Unrestrained (UR) mice and 
restrained mice from each of the 4 experimental groups were used. A 
total of 7 trials each were conducted with UR mice which were unin¬ 
fected or which were infected with L. mexicana. Ten trials were con¬ 
ducted with UR mice which were infected with P. yoelii and 10 with 
mice infected with both P. yoelii and L. mexicana. Restrained mice 
were anesthetized with nembutal (0.25 ml of a solution made up of 3 
parts nembutal to 7 parts physiological saline) 10 min prior to their 
introduction into the cage. These mice served as controls for each 
of the 4 experimental groups. Preliminary data indicated that 
mosquitoes fed equally well on restrained mice from each of the 4 
experimental groups. In light of this, only 2 control trials were 
conducted using restrained mice from each of the 4 experimental 
groups and data from these 8 tests were pooled. 
Mice were removed from the cages after 45 min and the mosqui¬ 
toes were aspirated back into the holding cartons using a mechanical 
aspirator. The surviving mosquitoes were killed by placing these 
containers into a freezer, and the mosquitoes were then counted and 
checked for the presence or absence of blood. 
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Activity cage experiments 
Mice from each of the four experimental groups were individu- 
ally placed in activity cages (Wahmann Manufacturing. Co.)* Each 
activity cage consisted of a wheel fitted with an automatic counter 
which recorded each half revolution in either direction. The daily 
number of revolutions were recorded for each activity wheel during a 
7 day control period and for a 3 week period following the inocula¬ 
tion of parasites. The experiment was replicated 4 times. The aver¬ 
age number of revolutions run by each group of mice was calculated 
and plotted. 
Core body temperature 
A YSI electronic tele-thermometer fitted with an electronic 
probe was used to monitor the core body temperatures of 10 mice from 
each experimental group. Temperatures were recorded every other day 
over the course of the experiment. Mean core body temperatures for 
each group of mice were calculated and plotted. 
Results 
Determination of parasitemia 
Mice which were inoculated with P. yoelii developed infections 
in which approximately 15% of the RBC were infected during peak 
parasitemia (Fig. 32). Plasmodium yoelii parasitemia rates were 
significantly enhanced when mice were concurrently infected with both 
P. zoelii and L. mexicana. Approximately 35% of the RBC were in- 
se mice during the height of the infection (Fig. 32). fected in the 
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These results correspond with those previously obtained during exper¬ 
iments on dual infections in BALB/c mice (Chapters 2 and 3). 
Mice infected with L. mexicana and P. yoelii did not develop 
lesions which were significantly larger or smaller than those which 
occurred in mice only infected with L. mexicana (because of this, 
data for the progression of L. mexicana infection are not presented). 
However, previous evidence (chapter 2) indicated that lesions in 
BALB/c mice only become detectable 3 weeks after parasite inocula¬ 
tion. We have previously demonstrated that mice infected with both 
L. mexicana and P. yoelii develop lesions which are significantly 
larger than those lesions which occur in mice only infected with L. 
mexicana (Chapters 2 and 3). Such differences normally become de¬ 
tectable within 5 weeks of parasite inoculation. Therefore, it was 
not surprising that differences in lesion development between these 
two groups of mice were not detected. 
Mosquito feeding experiments 
The mean number of A. aegypti remaining in each cage each day 
is shown in Figs. 33-35. More mosquitoes were recovered alive from 
cages containing restrained mice than from cages containing unre¬ 
strained animals. Although direct observations were not made, it is 
assumed that differences in mosquito mortality rates between control 
and experimental cages resulted primarily from defensive movements of 
unrestrained mice. Day (1981) reported that laboratory mice caught 
and ate mosquitoes. Some mortality which occurred in cages which 
contained unrestrained mice might have resulted from factors other 
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than host defensive behavior. Close examination of the cages occa¬ 
sionally revealed the presence of dead mosquitoes which were 
"trapped" in excrement voided by unrestrained mice. None of the re¬ 
strained mice produced urine or feces while anesthetized. Although 
we examined each cage for dead mosquitoes when the mice were removed 
from the cages, dead mosquitoes may have been consumed by the animals 
prior to our examination. It is therefore impossible to determine 
the exact cause of observed mortality differences. 
Mosquito engorgement success on mice from each experimental 
group is shown in Figs. 36-38. A. aegypti were unable to obtain 
blood from uninfected mice (Fig. 36) or from mice infected only with 
L. mexicana (Fig. 37). A small number of mosquitoes obtained blood 
from mice infected with P. yoelii only. Significant engorgement 
rates only occurred during peak parasitemia; however, less than 20% 
of the mosquitoes obtained blood during this period. Mosquitoes also 
obtained blood from mice infected with both P. yoelii and L. mexicana 
(Fig. 38). Almost 50% of the mosquitoes which were exposed to dually 
infected mice obtained blood during the period of peak parasitemia. 
Again, mosquito engorgement only occurred during this period. 
Activity cage experiments 
The activity patterns of mice from each of the 4 experimental 
groups are shown in Figs. 39-41. The number of revolutions ran by 
each mouse increased during the initial acclimation period (Figs 39- 
41). The animals presumably became accustomed to the activity wheels 
during this time. Uninfected mice normally ran at least 5,000 
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revolutions per wheel per day (Figs. 39-41). A great deal of varia¬ 
tion in daily activity occurred over the course of the experiment. 
Mice infected with P. yoelii became less active as the infection pro¬ 
gressed. These animals ran an average of 1,500 revolutions per day 
during the peak of the infection. Daily activity gradually increased 
following clearance of the parasites from the peripheral circulation 
(Fig. 39). Mice infected with L. mexicana remained as active as the 
uninfected mice throughout the experiment (Fig. 40). The daily ac¬ 
tivity patterns of mice infected with both P. yoelii and L. mexicana 
resembled those of mice only infected with P. yoelii; however, 
running on the activity wheel decreased almost entirely during peak 
Plasmodium infection (Fig. 41). This reduction in running was both 
more pronounced and of a longer duration than changes which occurred 
to mice infected with P. yoelii only. 
Core body temperature 
Uninfected mice maintained a core body temperature of approxi- 
mately 36.5 - 37.0°C throughout the course of the experiment (Figs. 
42-44). Mice infected with L. mexicana initially maintained this 
core body temperature. However, these mice gradually became hyper¬ 
thermic as the infection progressed. The core body temperature of 
these mice had stabilized between 37.5°C and 38.0°C at the conclusion 
of the experiment (Fig. 43). Mice infected with P. yoelu became 
slightly hypothermic at the peak of the infection (Fig. 42) as did 
mice infected with both P. yoelii and L. mexicana (Fig. 44). 
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Hypothermia in dually infected mice was more pronounced than that 
observed in mice infected only with P. yoelii (Figs. 42 & 44). 
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Figure 32. Plasmodium yoelii parasitemia in BALB/c mice 
infected with a) P. yoelii only (PYIM), and b) both P. yoelii 
and Leishmania mexicana (DIM). Parasites were inoculated on Day 
0 (+/- SE). 
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Figure 33. Mean number of Aedes aegypti remaining after 
exposure to a) restrained mice (RM), b) unrestrained uninfected 
mice (UR-UIM), and c) unrestrained Plasmodium yoelii infected 
mice (UR-PYIM). Parasites were inoculated on Day 0 (+/- SE). 
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Figure 34. Mean number of Aedes aegypti remaining after 
exposure to a) restrained mice (RM), b) unrestrained uninfected 
mice (UR-UIM), and c) unrestrained Leishmania mexicana infected 
mice (UR-LMIM). Parasites were inoculated on Day 0 (+/- SE). 
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Figure 35. Mean number of Aedes aegypti remaining after 
exposure to a) restrained mice (RM), b) unrestrained uninfected 
mice (UR-UIM), and c) unrestrained mice infected with both 
Plasmodium yoelii and Leishmania mexicana (UR-DIM). Parasites 
were inoculated on Day 0 (+/- SE). 
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Figure 36. Feeding success of Aedes aegypti when exposed 
to a) restrained mice (RM), b) unrestrained, uninfected mice 
(UR-UIM), and c) unrestrained Plasmodium yoelii infected mice 
(UR-PYIM). Parasites were inoculated on Day 0 ( + /- SE). 
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Figure 37. Feeding success of Aedes aegypti when exposed 
to a) restrained mice (RM), b) unrestrained, uninfected mice 
(UR-UIM), and c) unrestrained Leishmania mexicana infected mice 
(UR-LMIM). Parasites were inoculated on Day 0 (+/- SE). 
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Figure 38. Feeding success of Aedes aegypti when exposed 
to a) restrained mice (RM), b) unrestrained, uninfected mice 
(UR-UIM), and c) unrestrained mice infected with both 
Plasmodium yoe1ii and Leishmania mexicana (UR-DIM). Parasites 
were inoculated on Day 0 (+/- SE). 
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Figure 39. Mean daily activity of a) uninfected mice 
(UIM), and b) Plasmodium yoelii infected mice (PYIM). Parasites 
were inoculated on Day 0 (+/- SE). 
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Figure 40. Mean daily activity of a) uninfected mice 
(UIM), and b) Leishmania mexicana infected mice (LMIM). 
Parasites were inoculated on Day 0 (+/- SE). 
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Figure 41. Mean daily activity of a) uninfected mice 
(UIM), and b) mice infected with both Plasmodium yoelii and 
Leishmania mexicana (DIM). Parasites were inoculated on Day 0 
( + /- SE). 
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Figure 42. Mean body temperature of a) uninfected mice 
(UIM), and b) Plasmodium yoelii infected mice (PYIM). 
Parasites were inoculated on Day 0 (+/- SE). 
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Figure 43. Mean body temperature of a) uninfected mice 
(UIM), and b) Leishmania mexicana infected mice (LMIM). 
Parasites were inoculated on Day 0 (+/- SE). 
153 
(0o) 8jn;Bj0duj0i 
D
ay
s 
P
o
st
-I
n
o
c
u
la
ti
o
n
 
154 
Figure 44. Mean body temperature of a) uninfected mice 
(UIM), and b) mice infected with both Plasmodium yoelii and 
Leishmania mexicana (DIM). Parasites were inoculated on Day 0 
(+/- SE). 
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Discussion 
Numerous studies have shown that parasite manipulation of 
host/vector interplay can result in facilitated pathogen transmission 
(Molyneux & Jefferies 1986). Parasites can affect the probing abil¬ 
ity of infected insects (Anez & East 1984, Beach et al. 1985, Jenni 
et al. 1980, Rossignol et al. 1984), and certain arthropods locate 
blood from infected hosts more rapidly than from uninfected animals 
(Rossignol et al. 1985). Pathogen-mediated alteration of host behav¬ 
ior can increase vector engorgement rates on parasitemic hosts (Day & 
Edman 1984b, Day et al. 1983). 
Day and Edman (1983) found that mosquitoes were less effective 
at obtaining blood from mice infected with low virulence P. yoelii 
than from either P. berghei or P. chabaudi infected mice. Plasmodium 
yoelii is often associated with a more virulent malarial infection in 
naturally infected rodents (Carter & Walliker 1975, Killick-Kendrick 
1978). Day and Edman (1983) suggested that successful transmission 
of P. yoelii might depend upon the manipulation of host behavior by 
these associated parasites. Transmission of P. yoelii might be fa¬ 
vored if the host were concurrently infected with any other pathogen 
which modulates host defensive behavior (i.e., not just a more viru¬ 
lent species or strain of P1asmodium). Even if the concomitant 
pathogen did not directly influence host behavior, more mosquitoes 
might successfully engorge on dually infected hosts if the presence 
of a second parasite resulted in an enhanced malarial infection (as 
shown in Chapters 2, 3, and 4). 
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Core body temperature, host activity patterns, and mosquito 
engorgement success were used to assay the effect of P. yoelii and L. 
mexicana on host health. On the basis of these criteria, P. yoelii 
and L. mexicana proved to be relatively benign parasites of labora¬ 
tory mice. Neither parasite markedly affected core body temperature, 
although mice infected with L. mexicana became slightly hyperthermic 
by the conclusion of the experiment. This is in contrast to the 
slight hypothermia observed in mice infected with P. yoelii. In no 
instance did the hypothermia in these mice reach the low level 
recorded in mice infected with P. berghei or P. chabaudi (Day & Edman 
1984). 
Mice infected with L. mexicana remained as active as uninfected 
mice for the duration of the experiment. Mice infected with P. 
yoelii remained as active as uninfected mice for several days follow¬ 
ing parasite inoculation. A drop in daily activity coincided with an 
increase in parasitemia levels. The clearance of parasites from the 
peripheral circulatory system was associated with a rapid increase in 
daily activity. These alterations to daily activity were relatively 
small compared to the effects produced by P. berghei and P. chabaudi 
in laboratory mice (Day 1981). 
Although core body temperature and host activity can be used to 
assess host health, vector feeding success provides a more meaningful 
measure of epidemiologically significant changes in host health. 
Without blood uptake, subsequent transmission to a susceptible host 
cannot occur. Although A. aegypti is not a vector of either P. 
Zoelii or L. mexicana; however, it served to bioassay changes in host 
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anti-vector behavior. Mosquitoes were unable to obtain blood from 
either uninfected mice or from mice infected with L. mexicana. A few 
mosquitoes were able to engorge on mice infected with P. yoelii. 
Successful feeding only occurred for several days during peak para¬ 
sitemia. Whether the number of mosquitoes which obtained blood from 
laboratory mice infected with P. yoelii would be sufficient to main¬ 
tain transmission of the disease under natural conditions is not 
known. Nor is it known if similar blood-feeding feeding patterns 
occur in nature. Little evidence is available to indicate what 
proportion of mosquitoes must obtain blood in order for disease 
transmission to continue. However, under normal field conditions, 
only a fraction of all mosquitoes which engorge will survive long 
enough to transmit the parasite (Bruce-Chwatt 1985). Even if 
mosquitoes survive the sporogonic incubation period, not all 
mosquitoes will feed on susceptible hosts, nor will all cases of 
mosquito feeding result in infection. It is intuitive that the 
larger the number of mosquitoes which successfully engorge, the 
larger the number which will survive to develop salivary gland infec¬ 
tion. It is only these mosquitoes which are capable of parasite 
transmission (MacDonald 1957). 
Concurrent infection with P. yoelii and L. mexicana affected 
all parameters which were examined. Malarial infections in dually 
infected mice were much more severe than in mice infected with P. 
zoelii only. The progression of L. mexicana was identical in both 
groups of mice infected with that parasite. Alteration of the vari¬ 
ous parameters which were examined in this experiment appeared to 
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result from the abnormally severe malarial infection, and not from 
any variation in the progression of L. mexicana. For example, mice 
infected with P. yoelii became hypothermic and mice infected with L. 
mexicana became hyperthermic. All mice concurrently infected with 
both parasites became severely hypothermic, not hyperthermic. Daily 
activity patterns were also affected, with dually infected mice be¬ 
coming less active. 
Profound pathological changes occur during malarial infections. 
Erythrocyte destruction is accompanied by anemia and release of solu¬ 
ble substances into circulation. Endogenous pyrogen is released from 
leukocytes, resulting in release of prostaglandins and monoamines 
(Bruce-Chwatt 1985). Parasitized cells develop "knobs" on their sur¬ 
face which interfere with circulation in the capillaries. Resulting 
oxygen depletion can lead to lesion development in various organs 
(Bruce-Chwatt 1985). Conversely, pathology resulting from cutaneous 
leishmaniasis is primarily restricted to the site of lesion develop¬ 
ment (Molyneux & Ashford 1983). Inoculation of promastigotes by sand 
flies is followed by initial invasion of polymorphonuclear leucko- 
cytes to the site of infection. Ulceration results from a combina¬ 
tion of cellular infiltration, edema, and vasculitis leading to 
disruption of blood supply and consequent necrosis. Blood stream 
dissemination only occurs in rare instances (Marsden & Jones 1985). 
It is evident that malaria results in a systemic perturbation 
of host physiological function (Killick-Kendrick & Peters 1978), 
whereas cutaneous leishmaniasis affects localized tissue. Mice which 
were infected with both P. Zoelii and L. mexicana developed 
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abnormally high malarial infections. It is not surprising that 
modification of host defensive behavior occurred during this period 
of heightened P. yoelii parasitemia. 
Although the model used to test the role of dual infection to¬ 
wards vector feeding success is artificial (i.e., L. mexicana is 
found in South and Central America while P. yoelii is distributed in 
central Africa), the results obtained in this study may be suggestive 
of events in other epidemiological situations. Numerous studies have 
shown that disease enhancement can result from concomitant parasitic 
infections (Killick—Kendrick & Peters 1978). Modification of host 
behavior during concomitant infection would presumably promote vector 
feeding success in all instances where the host utilizes defensive 
behavior to prevent blood uptake. 
Chapter VIII 
FEEDING BEHAVIOR OF LUTZOMYIA LONGIPALPIS 
ON MICE INFECTED WITH LEISHMANIA MEXICANA AMAZONENSIS 
Introduction 
Leishmania mexicana is a major cause of cutaneous leishmaniasis 
in South and Central America (Lainson & Shaw 1972). Infection in the 
vertebrate host is initiated through the inoculation of promastigotes 
by sand flies. The amastigote forms reside in macrophages and are 
normally localized within discrete cutaneous nodules (Molyneux & Ash¬ 
ford 1983), although dissemination of the parasites may occur (Perez 
et al. 1979). Sand flies become infected with L. mexicana by feeding 
on areas rich in parasites. Selective feeding on cutaneous lesions 
would presumably facilitate transmission of L. mexicana. although the 
role of feeding site selection in infection of the vector has not 
been examined. 
Numerous studies have shown that host "defensive" behavior can 
prevent mosquitoes from successfully feeding on birds (Edman & Kale 
1971) and small mammals (Day & Edman 1984, Klowden & Lea 1979, Waage 
& Nondo 1982, Walker & Edman 1986). Day and Edman (1983) demon¬ 
strated that mice infected with malaria exhibited decreased anti¬ 
vector defensive behavior when gametocytes were most prevalent. This 
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behavioral manipulation would favor transmission of the parasite. 
Research on the role of host defensive behavior toward vector feeding 
success has thus far been limited to mosquitoes (Day & Edman 1984, 
Edman & Kale 1971, Klowden & Lea 1979, Waage & Nondo 1982, Walker & 
Edman 1986) and Reduviid bugs (Schofield 1985, Schofield & White 
1982, Schofield et al. 1986). The effect of host behavior on sand 
fly feeding success is not known, nor is the effect of Leishmania on 
host behavior. 
This study sought to determine whether sand flies preferen¬ 
tially fed on cutaneous lesions of mice infected with L. mexicana. 
The role of host behavior on the feeding success of L. longipalpis on 
uninfected mice and on mice infected with L. mexicana was also deter¬ 
mined . 
Materials and Methods 
Animals 
Female BALB/c mice were obtained from the Charles River Breed¬ 
ing Laboratory, Wilmington, Massachusetts. Mice weighed 25-30 grams 
and were 14-16 weeks old when used for experiments. 
Leishmaniasis 
Leishmania mexicana amazonensis (Walter Reed strain 227) was 
used. The source and history of this isolate have been described 
(Nolan et al. 1984). Eight-week old experimental animals were 
infected, using procedures previously described, with amastigotes 
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obtained from donor mice. Mice were used for experiments 6-8 wks 
after parasite inoculation. 
Sand flies 
Lutzomyia longipalpis (Lutz & Neiva) were reared using the 
techniques of Modi and Tesh (1983). Five-day old L. long ipalpis were 
aspirated out of adult holding cages and groups of 10 female flies 
placed in 30x30x30 cm plexiglass observation chambers. Flies were 
provided with cotton pledgets soaked with a 30% fructose solution. 
Fructose was removed after 24 hrs and only water provided. Experi¬ 
ments commenced 24 hrs later, when the flies were 7 days old. 
Observations 
Individual mice were anesthetized with Nembutal and laid ven¬ 
tral surface down in the center of a cage containing 10 female L. 
longipalpis. The front feet of the mice were tucked under the body, 
effectively preventing sand flies from feeding on these sites. Po¬ 
tential feeding sites therefore included: left and right hind feet, 
tail, eyelids (area of exposed skin around the eye), ears, and nose. 
The total surface area of each of these sites was calculated (by 
removing the skin from each site and spreading it over a grid) for 
uninfected mice (UIM) and infected mice (IM). All observations were 
made in late morning and early afternoon under fluorescent light. 
Statistical analyses followed methods of Snedecor and Cochran (1967). 
Feeding site location. Twenty IM and 10 UIM were individually 
exposed to groups of 10 L. longipalpis for 2 hrs. Locations where 
individual flies successfully imbibed blood 
were recorded. 
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Relationship of landing, probing and blood uptake. The feed¬ 
ing behavior of individual L. longipalpis was observed on UIM and on 
IM. Observations commenced with initial landing of the fly on the 
host and were continued until the flies left the host. Foraging and 
probing sites were recorded, as were locations where blood uptake oc¬ 
curred. Foraging sites were considered to be those areas of exposed 
skin where individual flies spent periods of 1 sec or more. Probing 
sites consisted of areas where the mouthparts were actually inserted 
into the skin, with or without blood uptake. Mice were exposed to L. 
longipalpis for 2 hr periods. Twenty replicates (200 flies) were ob¬ 
served on UIM and 40 replicates (400 flies) on IM. 
Duration of feeding. The length of time required by individual 
L. longipalpis to feed to repletion on each area of exposed skin on 
IM and UIM was determined. Feeding duration was defined as the in¬ 
terval between the insertion of mouthparts into the skin of the host 
and the withdrawal of mouthparts following blood uptake. Feeding 
bouts in which flies which withdrew the mouthparts prior to the 
appearance of blood in the abdomen were not considered. Feeding 
duration was recorded for 25 flies on UIM and 25 flies on IM. 
Role of host behavior towards sand fly feeding sucr.Pgg Groups 
of 10, 20, 30, 40, 50, or 60 female flies were placed in holding 
cages without water or fructose. Experiments commenced 48 hours 
later with the introduction of either an unrestrained or a restrained 
BALB/c mouse (uninfected or infected with L. mexicana) into the hold¬ 
ing cage. Restrained mice were anesthetized with Nembutal and laid 
ventral surface down in the center of the 
cage. Remaining L. 
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longipalpis were aspirated from the cage after 1 hour and the number 
of blood fed flies recorded. Experiments were replicated 17 times on 
uninfected mice and 8 times on infected mice. 
Results 
Feeding site location 
Fifty flies were observed feeding on UIM and 127 on IM (Table 
1). Flies successfully fed on all areas of exposed skin on both UIM 
and IM; however, the selection of feeding sites was significantly af¬ 
fected by the disease status of the host (Table 1). Flies exposed to 
UIM showed no clear preference for particular feeding sites, while 
flies feeding on IM fed predominantly on the infected foot. 
Relationship of landing, probing and blood uptake 
Fifty-six bouts were observed on UIM (Table 2) and 131 on IM 
(Table 3). Landing by L. longipalpis was significantly correlated 
with the total surface area of each site on both UIM (r=+0.96) and IM 
(r=+0.92). The high number of flies which landed on the infected 
foot of IM was not greater than expected based on the total surface 
area of the site (Chi-Square Goodness of Fit, P < 0.01). This sug¬ 
gested that the selection of landing sites occurred randomly. 
A small portion of all landings on UIM resulted in probing 
(Table 2); however, a greater percentage of flies probed on the eyes 
of UIM mice than expected (Table 4). Probing was much more frequent 
on IM than expected (based on an equal probability of probing at all 
sites). The higher than expected incidence of probing on IM resulted 
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from preferential probing on the infected foot (Tables 3 & 4). A 
corresponding decrease in the frequency of probing on the tail and on 
the uninfected foot of the IM occurred. Comparison of probing on UIH 
with probing on IM demonstrated that observed differences in probing 
behavior between groups were due almost entirely to this increase in 
the incidence of probing on the infected foot of IM (Table 5). 
Blood uptake occurred in 66.6% (8/12) of probes on UIM and 62.2% 
(28/45) of probes on IM (Tables 2-4). The uptake of blood was not 
significantly different on the various sites on a mouse except for a 
lower than expected frequency on the ears of IM), nor between UIM and 
IM (Tables 4-6). 
Duration of feeding 
The time required to feed to repletion by L. longipalpis ranged 
from 208 to 888 sec on UIM and 165 to 1669 sec on IM. The mean time 
required to feed to repletion on UIM and on IM did not differ greatly 
(Table 7). The length of time required to feed to repletion on par- 
ticular sites varied considerably (Table 7). 
Role of host behavior towards sand fly feeding auer.»«« 
Sand flies successfully fed on anesthetized mice, 
able to feed on unrestrained animals (Tables 8-9). The 
but were un- 
presence of 
- —icana did not affect feedi"S success on either unrestrained or 
restrained mice (Tables 8-9). 
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Table 1. Feeding site selection of female Lutzomyia 
longipalpis on uninfected mice and on mice infected 
with Leishmania mexicana amazonensis. 
Uninfected Mice Infected Mice 
Site 
No. 
Fed 
% of 
Total 
No. 
Fed 
% of 
Total X2 Testa 
Ear 11 22 11 8.7 5.86 * 
Eye 13 26 22 17.3 1.72 ns 
Nose 2 4 3 2.4 0.35 ns 
Tail 13 26 11 8.7 9.20 * 
Lft. Ft. 6 12 8 6.2 0.16 ns 
Rt. Ft.b 5 10 72 56.7 31.82 **** 
Totals - 50 100 127 100.0 
3. 
Significant values indicate that the percentage of 
flies feeding on specific sites on uninfected mice 
was different than the percentage of flies feeding 
on the same site on infected mice (X2 test for 
equality of 2 multinomials). 
b 
* 
Site of inoculation of L. mexicana in infected mice 
P < 0.05; 
**** 
- P < 0.00001; ns 
- not significant. 
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Table 2. Blood uptake by Lutzomyia longipalpis 
in relation to landing and to areas where probing 
occurred on uninfected mice. 
Site 
Surface 
o 
Area (cm ) 
No. of Flies 
Landing (%a) 
No. of 
Probes (%k) 
No. Blood 
Fed (%c) 
Ear 6.1 12 (21.4) 2 (16.6) 1 ( 8.3) 
Eye 0.4 8 (14.2) 5 (62.5) 3 (37.5) 
Nose 0.2 7 (12.5) 1 (14.2) 1 (14.2) 
Tail 6.4 12 (21.4) 2 (16.6) 1 ( 8.3) 
Lft. Ft. 2.7 8 (14.2) 1 (12.5) 1 (12.5) 
Rt. Ft.d 2.7 9 (16.1) 1 (11.1) 1 (11.1) 
Totals - 18.5 56 12 (21.4) 8 (14.2) 
- Percent of total landings on each site. 
- Percent of landings on each site which resulted 
in probing. 
Percent of landings on each site which resulted in 
blood uptake. 
d - Corresponds to inoculation site of L. mexicana in 
infected mice. 
Table 3. Blood uptake by Lutzomyia longipalpis in 
relation to landing sites and to areas where probing 
occurred on mice infected with Leishmania mexicana 
amazonensis. 
Site 
Surface 
Area (cm^) 
No. of Flies 
Landing (%a) 
No. of 
Probes (%b) 
No. Blood 
Fed (%c) 
Ear 6.1 23 (17.5) 6 (26.0) 1 ( 4.3) 
Eye 0.4 12 ( 9.1) 6 (50.0) 5 (41.6) 
Nose 0.2 11 ( 8.3) 2 (18.1) 1 ( 9.0) 
Tail 6.4 34 (25.9) 5 (14.7) 2 ( 5.8) 
Lft. Ft . 2.7 16 (12.2) 2 (12.5) 1 ( 6.2) 
Rt. Ft. d 6.1 35 (26.7) 24 (68.5) 18 (51.4) 
Totals 
- 21.9 131 45 (34.3) 28 (21.3) 
Percent of total landings on each site. 
Percent of landings on each site which resulted 
in probing. 
Percent of landings on each site which resulted 
in blood uptake. 
- Site of inoculation of L. mexicana. 
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Table 4. The conditional probability of probing (given 
landing) by Lutzomyia longipalpis on uninfected mice and 
on mice infected with Leishmania mexicana amazonensis. 
Uninfected Mice Infected Mice 
Feeding 
Site 
No 
Probe Probe X2 Testa Probe 
No 
Probe X2 Testa 
Ear 2 10 0.20 ns 6 17 0.49 ns 
Eye 5 3 9.35 * 6 6 1.43 ns 
Nose 1 6 0.24 ns 2 9 1.51 ns 
Tail 2 10 0.20 ns 5 29 7.85 
* 
Lft. Ft. 1 7 0.44 ns 2 14 3.85 
* 
Rt. Ft.b 1 8 0.67 ns 24 11 24.80 **** 
Totals - 12 44 45 86 
Significant values indicate that the incidence of 
probing was different than expected based on an 
eq^ai probability of probing at each site 
(X Test for equality of 2 multinomials). 
b Site of inoculation of L. mexicana in infected mice. 
* - P < 0.05; **** - p < 0.00001; ns - not significant. 
Table 5. The conditional probability of blood uptake 
(given probing) by Lutzomyia longipalpis on uninfected 
mice and on mice infected with Leishmania mexicana 
amazonensis. 
Uninfected Mice Infected Mice 
Site Blood 
No 
Blood X2 Test3 Blood 
No 
Blood X2 Test3 
Ear 1 1 0.13 ns 1 5 _ fc 6.11 
Eye 3 2 0.008 ns 5 1 1.31 ns 
Nose 1 0 0.10 ns 1 1 0.13 ns 
Tail 1 1 0.13 ns 2 3 1.18 ns 
Lft. Ft. 1 0 0.10 ns 1 1 0.13 ns 
Rt. Ft.b 1 0 0.13 ns 18 6 3.57 ns 
Totals - 8 4 28 17 
3i 
Significant values indicate that the incidence of 
blood uptake was different than expected based on 
an^equal probability of blood uptake at each site 
(X Test for equality of 2 multinomials). 
b 
* 
Site of inoculation of L. 
P < 0.05; **** 
mexicana in infected mice. 
- P < 0.00001; ns 
- not significant. 
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Table 6. A Comparison of the probability of probing 
(given landing) or the probability of blood uptake 
(given probing) on uninfected mice with the probability 
of probing or the probability of blood uptake on mice 
infected with Leishmania mexicana amazonensis. 
X2 Valueab 
Site 
Probing vs. 
Not Probing 
Blood Uptake vs. 
No Blood Uptake 
Ear 0.44 ns 0.75 ns 
Eye 0.31 ns 0.76 ns 
Nose 0.04 ns 2.00 ns 
Tail 0.02 ns 0.05 ns 
Lft. Ft. 0.00 ns 2.00 ns 
Rt. Ft.c * 19.27 0.47 ns 
Totals - 20.10 * 0.01 ns 
2 
- X for equality of proportions. 
- Significant values indicate that probing or blood 
uptake on infected mice was different than probing 
or blood uptake on uninfected mice. 
Site of inoculation of L. mexicana in infected mice. 
- P <( 0.05; ns - Not significant 
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Table 7. Duration of feeding of Lutzomyia longipalpis 
on uninfected mice and on mice infected with Leishmania 
mexicana amazonensis. 
Duration of Feeding 
On Uninfected Mice On Infected Mice 
Site 
No. 
Fed 
Mean Time in secs 
to Feed (+/-SE) 
No. 
Fed 
Mean Time in secs 
to Feed (+/-SE) 
Ear 7 391 (52.5) 1 331 
Eye 4 643 (66.4) 5 474 (116.2) 
Nose — — 
— 
\ 
1 165 
Tail 6 575 (52.8) 1 749 
Lft. Ft. 4 442 (117.0) 4 779 (166.7) 
Rt. Ft.a 4 469 (143.6) 13 573 (105.8) 
Totals - 25 488 (38.2) 25 569 (68.4) 
Site of inoculation of Leishmania mexicana in infectpH 
mice. 
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Table 8. Comparison of the feeding success of Lutzomyia 
longipalpis on restrained mice and on unrestrained 
uninfected mice. 
Host 
Condition 
Sand fly 
Group 
Size 
No. of 
Tests 
No. of 
Blood 
Flies 
Fed (?) 
Restrained 0-10 2 3/ 15 (20.00) 
11-20 10 91/177 (51.41) 
21-30 3 42/ 74 (56.75) 
31-40 0 — — 
41-50 1 25/ 42 (59.52) 
51-60 1 26/ 55 (47.27) 
Total 17 187/363 (51.51) 
Unrestrained 0-10 2 0/ 17 (0.00) 
11-20 10 2/175 (1.14) 
21-30 2 1/ 75 (1.33) 
31-40 2 0/ 75 (0.00) 
41-50 0 — 
— 
51-60 0 — 
— 
Total 17 3/342 (0.87) 
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Table 9. Comparison of the feeding success of Lutzomyia 
longipalpis on restrained mice and on unrestrained mice 
infected with Leishmania mexicana amazonensis. 
Host 
Condition 
Sand fly 
Group 
Size 
No. of 
Tests 
No. of 
Blood 
Flies 
Fed (%) 
Restrained 0-10 0 — — 
11-20 6 58/108 (53.70) 
21-30 2 23/ 48 (47.91) 
Total 8 81/156 (51.92) 
Unrestrained 0-10 0 — — 
11-20 7 2/125 (1.60) 
21-30 1 0/ 22 (0.00) 
Total 17 2/147 (1.36) 
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Discussion 
Feeding site location 
Lutzomyia longipalpis fed randomly on UIM in this study. The 
feeding behavior of this fly appears to be similar to that of mos¬ 
quitoes, which land and forage indiscriminately on small rodents and 
racoons (Magnarelli 1979, Walker & Edman 1985). This is in contrast 
to the specific landing site selection shown by some Tabanidae on 
cattle (Hollander & Wright 1980, Magnarelli & Anderson 1980, Mullens 
& Gerhardt 1979). When L. longipalpis fed on mice infected with L. 
g^lcapa the? Preferentially fed on the cutaneous lesions of the ani¬ 
mals. No attempt was made to determine if the selection of specific 
feeding sites resulted from differential landing, probing or blood 
uptake rates, nor were actual infection rates determined. In spite 
of this, selective feeding on these parasite-rich areas by L. 
longipalpis could clearly result in increased vector infection rates. 
Certain sand flies have limited access to blood in normal human 
skin, due to the shortness of the labrum compared to the thickness of 
the epidermis (Lewis 1987). In patients with post kala-azar dermal 
leishmaniasis, parasites are often concentrated in cutaneous nodules 
(Sen Gupta 1964, Indian Council of Medical Research 1980). The epi¬ 
dermis in these nodules is greatly effaced, with the blood vessels 
dilated in the superficial dermis (Sen Gupta & Bhattachargee 1953). 
Lewis (1987) suggested that Phlebotomus argentipes should be able to 
locate blood, and hence parasites, more easily from these nodules 
than from normal skin. 
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BALB/c mice infected with L. mexicana develop lesions in which 
the epidermis is greatly distended. Increased feeding on these 
lesions by L. longipalpis could have resulted from: 1) an increase 
in landing on the lesion (compared to the uninfected foot) due to the 
increased surface area of the lesion, 2) an increase in the attrac¬ 
tiveness of the lesion for L. longipalpis, 3) selective probing on 
the lesion once flies had landed, or 4) more successful blood uptake 
on the lesion. These possibilities were examined in greater detail 
in subsequent experiments. 
Relationship of landing, probing and blood uptake 
The increased blood uptake by L. longipalpis on IM resulted 
entirely from differences in the probing behavior of the flies on 
these mice. Lutzomyia longipalpis exhibited no clear preference for 
landing on lesions, nor was uptake of blood more efficient at these 
sites once probing was initiated. Probing occurred more frequently 
on the infected foot of IM than on all other areas, with the excep- 
tion of the eyes of UIM and IM. 
Numerous studies have shown that the manipulation of host- 
vector interactions by parasites can facilitate pathogen transmission 
(Molyneux & Jefferies 1986). Enhanced disease transmission can re¬ 
sult from changes in the probing ability of infected insects (Anez & 
East 1984, Beach et al. 1985, Jenni et al. 1980, Rossignol et al. 
1984), from increased blood finding success of arthropods on para- 
sitemic hosts (Rossignol et al. 1985), and from changes in the 
efficacy of defensive behaviors of infected animals (Day & Edman 
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1983). Rossignol et al. (1985) found that blood uptake was facili¬ 
tated in animals infected with Plasmodium chabaudi or Rift Valley 
fever virus once probing was initiated. We suggest that pathological 
changes in the epidermis produced during L. mexicana infections may 
also result in enhanced disease transmission (due to increased feed¬ 
ing on those areas where parasites are usually found). Unlike the 
report by Rossignol et al. (1985); however, these data suggest that 
facilitated blood uptake may result from factors that come into play 
prior to the initiation of feeding. The precise mechanism by which 
this occurs is not known. 
Duration of feeding 
Blood-feeding insects face certain risks during host contact 
(Gillet 1967, Rossignol et al. 1985). The predicted strategy for 
blood-feeding insects therefore consists of a maximization of nutri¬ 
ent intake rate and a minimization of time required to obtain a blood 
meal (Daniel & Kingsolver 1983). 
In contrast to reports on rapid feeding by mosquitoes (Mellink 
et al. 1982, Walker & Edman 1986) and by the sand fly, Lutzomvia 
Orestes (Mendoza et al. 1983), L. longipalpj, fed extremely slowly on 
both IM and UIM. Based on feeding speed alone, blood feeding by this 
fly appears to be a relatively inefficient process. A combination of 
Slow feeding by the vector and host defensive behavior may have 
contributed to the inability of L. loalpalpi. to feed on both unre¬ 
strained UIM and unrestrained IM in these experiments. 
179 
Many vertebrates possess behavioral repertoires which limit the 
duration of host/vector contact (Day & Edman 1984, Edman & Kale 1971, 
Waage & Nondo 1982, Walker & Edman 1986). Rossignol et al. (1985) 
suggested that mutualism between parasite and vector could result in 
a decrease in the duration of feeding, thereby favoring parasite up¬ 
take. Unlike P. chabaudi and Rift Valley fever virus (Rossignol et 
al. 1985), Leishmania mexicana does not appear to affect vector feed¬ 
ing speed. 
Role of host behavior towards sand fly feeding success 
Day and Edman (1984) found that laboratory mice were highly 
defensive towards Aedes aegypti, Anopheles quadrimaculatus, Culex 
—ipalpisi and Culex quinquefasciatus. Unrestrained mice prevented 
mosquitoes from successfully feeding in most instances. We have 
found that unrestrained mice were equally as defensive towards L. 
longipalpis, allowing only a small portion of all flies to feed. 
This is the first demonstration that the blood feeding success of 
Diptera other than mosquitoes is affected by host defensive re¬ 
sponses. Infection with L. mexicana did not affect host defensive 
behavior towards sand flies. Although L. mexicana infections in 
BALB/c mice appear debilitating, transmission is not favored by a 
manipulation of host behavior. 
Feeding Behavior of Lutzomyla longipalpis on mice 
Transmission of arthropod-borne diseases depends on the suc¬ 
cessful uptake of pathogens by a vector. When parasites are local¬ 
ized in discrete areas, as with New World cutaneous leishmaniasis, 
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preferential selection of feeding sites could result in increased 
vector infection rates. Pathogens which are systemically distributed 
presumably would not be affected by feeding site selection. Analysis 
of data suggests that factors associated with L. mexicana infections 
in BALB/c mice contribute to feeding on those areas where parasites 
presumably are most frequent. We have not attempted to determine if 
preferential feeding site selection would be reflected in actual sand 
fly infection rates. 
I 
Chapter IX 
SUMMARY OF CONCLUSIONS 
The following conclusions were obtained during this study: 
1) BALB/c and C/57 mice infected with Plasmodium yoelii developed an 
infection that lasted 14-16 days. Peak parasitemia occurred 
approximately 10 days after parasite inoculation, when 10-15% 
of all erythrocytes were infected. 
2) BALB/c mice infected with Leishmania mexicana amazonensis devel¬ 
oped lesions at the site of inoculation. Parasites rapidly 
disseminated throughout the body of these mice. Lesions devel¬ 
oped more rapidly when the infective inocula was increased; 
however, the outcome of the infection was consistent irregard— 
less of the infective dose. 
3) C/57 mice infected with L. mexicana amazonensis developed cuta¬ 
neous lesions at the site of inoculation. The size of the 
lesions increased gradually until they reached a maximum 
diameter 10-15 weeks after parasite inoculation. Gradual 
healing occurred thereafter. No parasite dissemination was 
observed. 
4) Mice infected with both P. yoelii and L. mexicana developed malar¬ 
ial infections which were more severe than those observed when 
mice were only infected with P. yoelii. Twenty to 35% of all 
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erythrocytes were infected during peak P. yoelii parasitemia in 
these dually infected mice. Infections were enhanced when: i) 
both parasites were inoculated within 2 days of each other, ii) 
when L. mexicana was inoculated 3 weeks prior to P. yoelii, and 
iii) when L. mexicana was inoculated 12 weeks prior to P. 
yoelii. 
5) BALB/c and C/57 mice infected with both P. yoelii and L. mexicana 
amazonensis developed Leishmania infections which were more 
severe than those observed when mice were only infected with L. 
mexicana. Mice infected with both P. yoelii and L. mexicana 
developed lesions which were significantly larger than those in 
control mice when: i) both parasites were inoculated within 2 
days of each other, ii) when L. mexicana was inoculated 3 weeks 
prior to P. yoelii, iii) when P. yoelii was inoculated 3 weeks 
prior to L. mexicana, and iv) when P. yoelii was inoculated 12 
weeks prior to L. mexicana (C/57 mice). 
6) Several C/57 mice which were infected with both P. yoelii and L. 
mexicana developed disseminated lesions which did not heal 
spontaneously. As previously stated, such dissemination was 
never observed in mice only infected with L. mexicana. 
7) Infection with Plasmodium or Leishmania is associated with a well 
documented suppression of immune function. The enhanced para¬ 
sitemia that resulted from infection with both P. yoelii and L. 
mexicana presumably results from these immunosuppressive ef¬ 
fects. Drugs which affect immune function could theoretically 
be used to treat these infections. Agents which modulate T 
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suppressor cell function were used in an attempt to treat L. 
mexicana infections in BALB/c and C/57 mice. Cimetidine and 
2'-deoxyguanosine were as effective as pentostam (an agent with 
known anti-Leishmanial activity) at controlling lesion develop¬ 
ment in these mice. Varying the infective dose used to initi¬ 
ate infections affected the capacity of these drugs to treat 
clinical symptoms. Further research on the capacity of immune 
modulation for the treatment of leishmaniasis is warranted. 
8) Treatment with pentostam resulted in more severe malaria in mice 
only infected with P. yoelii and in mice infected with both P. 
yoelii and L. mexicana. 
9) Cimetidine limited the development of L. mexicana in mice infected 
with this parasite alone and in mice concurrently infected with 
P. yoelii. Cimetidine did not affect the development of P. 
y°elii in mice only infected with that parasite; however, P. 
y°elii infection was markedly limited in mice concurrently 
infected with L. mexicana. This indicated that manipulation of 
one infection (L. mexicana) effectively limited the development 
of a concomitant pathogen (P. yoelii). Such control presumably 
resulted from the immuno-modulatory effects of cimetidine. 
10) BALB/c mice were extremely efficient at preventing blood seeking 
mosquitoes (Aedes aegypti) from feeding. 
11) Mosquitoes which were exposed to mice infected with P. yoelii 
were only able to engorge during a 3-4 day period. This 
increase in feeding success was associated with the period of 
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maximum parasitemia. Very few mosquitoes ever obtained blood 
from uninfected mice or from mice infected with L. mexicana. 
12) Significantly more mosquitoes engorged on mice infected with both 
P. yoelii and L. mexicana than on uninfected mice, on mice only 
infected with L. mexicana, or on mice only infected with P. 
yoelii. 
13) Uninfected mice maintained a core body temperature of approxi¬ 
mately 36.5-37°C Mice infected with L. mexicana became hyper¬ 
thermic by the conclusion of the experiment, with the mean 
daily temperature rising gradually to 38°C. Mice infected with 
P. yoelii or with both P. yoelii and L. mexicana became hypo¬ 
thermic during the crisis phase of P. yoelii infection. The 
mean core body temperature of mice infected with P. yoelii or 
dropped to 36.2°C, while that of mice infected with both P. 
yoelii and L. mexicana dropped to 34.1°C. 
14) The daily activity of uninfected mice and L. mexicana infected 
mice remained constant over the course of the experiment 
(approximately 5,000 revolutions per day on each activity 
wheel). Mice infected with P. yoelii or with both P. yoelii 
and L. mexicana were less active during peak malarial infection 
than at other times. 
15) Sand flies (Lutzomyia longipalpis) were unable to feed on unre¬ 
strained, uninfected mice or on unrestrained, L. mexicana in¬ 
fected mice. Sand fly engorgement was prevented by defensive 
movements of these animals. 
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16) Lutzomyia longipalpis were able to feed on restrained mice. 
Flies preferentially fed on the cutaneous lesions of mice 
infected with L. mexicana. This preference resulted from 
selective probing on the lesions, and not from a non-random 
choice of landing site nor from facilitated blood uptake once 
probing had commenced. 
Outbreaks of leishmaniasis have historically followed epidemics 
of malaria in certain geographical areas (Pampiglione et al. 1974). 
This temporal coincidence presumably results from the increased 
production of mosquitoes and sand flies during periods of favorable 
environmental conditions (Pampiglione et al. 1974). The importance 
of vector abundance towards the epidemiology of these diseases was 
highlighted during the World Health Organization's malaria eradica¬ 
tion campaign. Following the widespread application of DDT during 
the campaign, the incidence of leishmaniasis (Corradetti 1952, Hertig 
1949, Lysenko 1971, Nadim & Araini 1970, Seyedi-Rashiti & Nadim 1975) 
and other Phlebotomus-borne diseases (Hertig 1949, Hadjinicolaou 
1958, Tesh & Papaevangelou 1977) dropped markedly in areas where the 
pesticide was sprayed. This decrease presumably resulted from the 
elimination of endophilic sand flies by the pesticide. 
Although sand fly abundance may be the most important factor 
contributing to the development of epidemic leishmaniasis, other fac- 
tors may also be relevant. Pampiglione (1974) suggested that stress 
such as epidemic malaria or famine would affect the competence of the 
host immune system. This perturbation would transform an otherwise 
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inapparent Leishmania infection into a clinically evident case. 
Evidence has shown that clinically apparent cases of leishmaniasis 
comprise a small fraction of all infections (Esterre et al. 1987, 
Fuller et al. 1976 1979, Pampiglione et al. 1974), suggesting that 
some unknown factor(s) affect the progression of the parasites in the 
host. 
The immunological competence of an organism is crucial to the 
epidemiology of all infectious diseases. The nutritional state of 
the host and the presence or absence of concomitant infections are 
key factors which can modulate immune competence (Harrison et al. 
1986, Dowd & Heatley 1984, Killick-Kendrick & Peters 1978). The 
development of protective immunity to L. mexicana and L. donovoni is 
clearly affected by protein malnutrition (Harrison et al. 1986, Perez 
et al. 1984), and there appears to be a reciprocal relationship 
between undernutrition and the development of visceral leishmaniasis 
(Harrison et al. 1986). Although Walton et al. (1973) and Pampig¬ 
lione et al. (1974) suggested that tuberculosis or malaria might 
affect the course of a Leishmania infection, little research has been 
directed towards the role concomitant infections might have on the 
development of the disease. 
These results clearly demonstrate the effects concomitant in- 
fection with Plasmodium zoelii and Leishmania mexicana amazonensis 
can have in laboratory mice. Not only were the clinical symptoms of 
each disease enhanced during dual infections, but factors which af¬ 
fect vector feeding success (and thereby disease transmission) were 
altered. Although the combination of Leishmania mexicana and 
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Plasmodium yoelii in BALB/c mice is an artificial system, the results 
obtained during this study may be applicable to other, more realis¬ 
tic, epidemiological situations. 
Perturbation of the host immune system may been responsible for 
the disease enhancement which occurred in mice infected with P. 
yoelii and L. mexicana. It seemed plausible that agents which 
modulate immune function might be effective against Leishmania or 
Plasmodium infections. We examined the effects of cimetidine, rani¬ 
tidine, and 2'-deoxyguanosine on the development of leishmaniasis in 
BALB/c and C/57 mice. Cimetidine and ranitidine inhibit the activity 
of T suppressor cells by binding to the H2 histamine receptor 
(Zapata-Sirvent et al. 1985, Henry et al. 1980), while 2•-deoxyguano- 
sine inhibits the replication of these cells (Bril et al. 1984). 
Each of these agents limited the development of lesions in BALB/c 
mice. The control was comparable to, or better, than that obtained 
using pentostam. However, in no instance did any of these three 
agents completely eliminate all symptoms of the disease. These data 
are in agreement with those of Osband et al. (1981) and Gifford et 
al. (1981), who found that the immuno-restorative effect of cimeti- 
dine slowed the development of a given disease rather than eliminat¬ 
ing all symptoms. Mucocutaneous and diffuse cutaneous leishmaniasis 
respond poorly to chemotherapy unless an effective immune response is 
initiated. Use of agents that activate immune function may have 
great value for the treatment of these forms of leishmaniasis. 
Further research on the therapeutic effects of immuno modulating 
agents against infectious diseases is certainly warranted. 
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Very few studies have examined the influence that a chemothera¬ 
peutic agent aimed at one parasite can have on the development of 
concomitant pathogens. The system we have been using proved to be an 
ideal model with which to examine this issue. The results clearly 
indicated that the agents used to treat one disease can have an 
effect on the progression of an unrelated pathogen. Pentostam is the 
drug of choice for the treatment of leishmaniasis. It is fairly 
effective, cheap, and the side-effects are normally mild (Marsden & 
Jones 1985). Based on our studies with laboratory mice, caution 
should be exercised when treating patients who might also have 
malaria. Mice that were infected with P. yoelii and were treated 
with pentostam developed more severe infections than control mice. 
When pentostam was used to treat the Leishmania infection in mice 
infected with both P. yoelii and L. mexicana, the malaria was less 
severe than the infection in control mice infected with both para¬ 
sites. However, this infection was still more severe than that in 
control mice that were only infected with P. yoelii. Cimetidine 
proved to be as effective as pentostam at limiting the development of 
leishmaniasis in BALB/c mice. However, all mice treated with cimeti¬ 
dine (including those concurrently infected with P. yoelii and L. 
mexicana) developed malarial infections which were less severe than 
that observed in control animals. These results clearly indicate 
that prior to the initiation of chemotherapy, considerable care 
should be taken to determine what concomitant parasites infect a 
given host. It is evident that chemotherapeutic agents may adversely 
affect host health in some instances. 
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Vector-borne diseases depend upon vector contact with an 
infected host and, following an appropriate extrinsic incubation 
period, subsequent feeding on a susceptible organism. Previous 
research has shown that rodents and certain birds use defensive 
movements to prevent mosquitoes from engorging (Day & Edman 1984b, 
Edman & Kale 1971, Edman et al. 1972 1974, Walker & Edman 1986). Day 
& Edman (1983) found that infection with P. berghei or P. chabaudi 
affected host behavior so that vector feeding success was facili¬ 
tated. However, infection with P. yoelii did not significantly 
affect host behavior. Mosquitoes attempting to feed on mice infected 
with P. yoelii were much less successful at engorging than on mice 
infected with P. berghei or P. chabaudi (Day & Edman 1983). 
We have shown that mice concurrently infected with P. yoelii 
and L. mexicana develop more severe malaria than that which occurs in 
mice only infected with P. yoelii. Aedes aegypti were only success¬ 
ful at feeding on these dually infected mice during the crisis phase 
Plasrnodium infection. These mosquitoes were unable to engorge 
on uninfected mice or on mice infected with L. mexicana. Very few A. 
^Y?ti were able to feed on mice only infected with P. yoelii. The 
other parameters which were examined were also significantly affected 
in mice infected with both parasites. The mean core body temperature 
and the mean amount of daily activity dropped markedly during the 
crisis phase of the malarial infection in mice infected with both P. 
^elil and -* gexicana. These parameters were also affected in mice 
only infected with P. yoelii; however, the level of daily activity 
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and the mean core body temperature decreased to a lesser degree than 
that observed in dually infected mice. 
The behavioral and physiological changes which were noted in 
dually infected mice resulted from the increased severity of the 
Plasmodium infection. No comparable changes were noted in any of the 
other groups of mice, although similar, but less marked, changes 
occurred in mice only infected with P. yoelii. 
It appears that mosquitoes would engorge more frequently on 
rodents concurrently infected with P. yoelii and a Leishmania sp. 
than on mice infected with either parasite alone. Malarial transmis¬ 
sion would presumably be facilitated by this selective process. The 
transmission of leishmaniasis might also be favored by concurrent 
infection with these pathogens, as mice are extremely effective at 
preventing sand flies from engorging. This possibility remains unan¬ 
swered; however, as rodents serve as the primary reservoir for many 
forms of leishmaniasis, this issue is especially relevant. 
Cutaneous leishmaniasis is unusual among parasitic diseases in 
that the pathogens are restricted to localized sites. Vectors 
presumably become infected by feeding on these parasite rich areas. 
Lutzomyia longipalpis selectively fed on the lesions of anesthetized 
L. mexicana infected mice. This preferential selection of feeding 
site did not result from discrimination during landing. However, 
once landing had taken place, the flies probed more frequently on 
lesions than on other sites. The probability of successfully obtain¬ 
ing blood once probing had commenced was equal on all sites. This 
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selective process presumably facilitates the transmission of leishma¬ 
niasis . 
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